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ABSTRACT OF THE DISSERTATION
Mathematical models for assessment of human health risk of pathogens in the environment
By
Srikiran Chandrasekaran
Doctor of Philosophy in Mathematical, Computational and Systems Biology
University of California, Irvine, 2019
Professor Sunny Jiang, Chair
Microbial pathogens in the environment present a growing threat to human health. They are
found in waters used for recreation, irrigation etc., which present a multitude of pathways
in which a person may be exposed to them. Moreover, the increasing interest in reusing
treated wastewater raises questions of water quality and associated public health risks. The
overarching goal of my dissertation is to develop quantitative tools to improve the accuracy
of methods used to assess this risk and provide insights into disease development. I hypoth-
esize that mathematical models rooted in well-grounded theory and data can augment the
overall understanding of microbial risk and steer experiments in the most productive direc-
tion. My specific aims are: 1) To quantify the health risk posed by norovirus-contaminated
water used for lettuce irrigation, by means of a dynamic transport model 2) To develop
a dose-response framework applicable for antibiotic resistant bacteria, specifically the hu-
man enteric pathogen, Escherichia coli 3) To develop a modeling framework to probe the
importance of cooperativity in helping Staphylococcus aureus establish skin infections. In
my research, I have constructed a transport model using ordinary differential equations to
predict the norovirus load in lettuce at harvest given the load in the irrigation water. By
fitting this model to published experimental data, I found that attachment of the virus to
the growth medium strongly influences the amount of virus in lettuce at harvest. Towards
the second aim, I have used stochastic processes to develop an analytical expression for E.
xi
coli dose-response. I then fitted this to clinical data and extended the model to predict,
for the first time, the risk posed by a mixture of antibiotic sensitive and antibiotic resistant
strains. Towards the third aim, I have developed a two-compartment stochastic model with
cooperativity between cells to predict S. aureus dose-response. Using experimental data to
reject the hypothesis of absence of cooperativity, I show the possible role of quorum sensing
in S. aureus establishing skin infections. The outcomes of this research will enable better
understanding of microbial risk associated with environmental exposure and improve human
health protection.
xii
Chapter 1
Introduction
1.1 Background
With the growing population and limited freshwater resources, there is increased interest
in water conservation practices like using recycled wastewater and hydroponic agriculture.
The presence of pathogens in the associated environmental compartments exposes a large
fraction of the general populace to infection risks. Therefore, a need of the hour is ensuring
that our infrastructure meets the safety requirements designed to protect human health.
Proper disposal and treatment of wastes generated at hospitals, industries and residences
help meet this goal by reducing the pathogen loads in the environment. However, complete
elimination of pathogens is not an option [33]. Therefore, a framework to quantify the
threat to human health is desired. The popularly adopted framework is called Quantitative
Microbial Risk Assessment or QMRA [57].
With the growing population and limited freshwater resources, there is increased interest in
water conservation practices like using recycled wastewater and hydroponic agriculture. The
presence of pathogens in the associated environmental compartments exposes a significant
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fraction of the general populace to infection risks. Therefore, a need of the hour is ensuring
that our infrastructure meets the safety requirements designed to protect human health.
Proper disposal and treatment of wastes generated at hospitals, industries, and residences
help achieve this goal by reducing the pathogen loads in the environment. However, complete
elimination of pathogens is not an option [33]. Therefore, a framework to quantify the
threat to human health is desired. The popularly adopted framework is called Quantitative
Microbial Risk Assessment or QMRA [57].
The main tenets of QMRA are as follows [57]: 1) hazard identification; 2) exposure assess-
ment; 3) dose-response modeling; 4) risk characterization, and 5) risk management. Hazard
identification constitutes deciding on the system of interest and listing out the pathogens
present/expected in that system. After identifying the hazard, the interaction of people with
the system are modeled to quantify exposure to the pathogen(s). Suppose the system of in-
terest is a particular lake used for recreation, and the hazard identified is E. coli. Exposure
assessment would entail enumerating the E. coli finally ingested by the person (or the dose).
These processes have a lot of associated variability and uncertainty. Therefore, quantities are
stratified by groups (age of swimmers, seasonal changes in pathogen concentration) or rep-
resented by distributions rather than point estimates. Estimating the risk while accounting
for these variabilities and uncertainties is done by Monte Carlo sampling.
Dose-response models (DRMs) relate the number of the pathogen (dose) to the probability
of a person falling ill (response or risk). They are constructed with data from clinical
trials in which a predetermined dose of pathogens is administered to a cohort of subjects
and the number falling ill counted. The latter is then divided by the total number of
subjects to reflect the probability of a single person falling ill. This process is repeated for
different pathogen doses to generate data for the models. While these clinical trials may
use animals, datasets generated from human trials are preferred since they better reflect the
human situation. Popular DRMs are the exponential and beta-Poisson models [57]. DRMs
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for different pathogens may share the same functional form but differ in the numerical values
of model parameters as a consequence of the biological differences between the pathogens.
Risk characterization involves calculating the risk posed by the hazard by integrating the
output of the exposure assessment (dose) with the DRM of choice for that pathogen. One
then compares these estimates with guidelines established by the U.S. Environmental Protec-
tion Agency (EPA) or the World Health Organization (WHO). Based on these comparisons,
risk management measures can be investigated in an iterative process by computing the risk
posed by the intervention measures.
1.2 Hypothesis
The larger topic of my interest is in building mathematical models to augment our under-
standing of microbial risk assessment. The system encompassing pathogens in the environ-
ment, and their interaction with humans is complex. Important variables like the weather,
the habits/demographics of the people under consideration, and the pathogen’s health ef-
fects must be accounted for when making decisions to safeguard human health. Experiments
spanning this entire scale are not feasible on accounts of the size of the system and the vari-
ability at each step. Mathematical modeling becomes indispensable in deriving insights and
is the cornerstone of microbial risk analyses.
Nevertheless, I believe that the models in this field abstract away important details and
favor simplified computational approaches for their parsimony and ease of use. Examples in-
clude the DRMs, such as exponential or beta-Poisson DRMs discussed above. I hypothesize
that mathematical models that account for these details and leverage sophisticated compu-
tational techniques open up new avenues of scientific inquiry and bring existing paradigms
into question. Besides, they can increase the accuracy of risk estimates and help generate
3
experimentally testable hypotheses that aid risk management.
1.3 Objectives
I aim to investigate this hypothesis by attempting to answer the following three specific
questions: 1) if the viral load in the water used to irrigate agricultural produce is known,
can the safety of consuming the resulting produce be determined? 2) can we use existing
data on dose-response to develop a predictive understanding of dose-response of antibiotic-
resistant bacteria (ARB)? and, 3) how do we mathematically investigate the presence or
absence of cooperativity between individual bacteria in establishing infection? I motivate
these questions below.
Limited freshwater supplies coupled with the increasing demand for it exert stress on the
water security of the populace. Using recycled wastewater for irrigating agricultural produce
is a sustainable way forward that has received much attention. However, this alternative
is not without risk. Pathogens present in the irrigation water can enter the food supply,
causing outbreaks of different diseases when contaminated produce is consumed uncooked.
When pathogens adhere to the surfaces of the plant, they can be washed off or treated
with UV radiation. However, viruses sometimes find their way into the vasculature of the
produce where they are shielded from treatment and can thus cause disease. The question
then is to find the relationship between viral loads in the input irrigation water (which is
easily measured) and the viral loads in the produce to understand its safety for consumption.
Using a simple output to input ratio may suffice to predict the risk but does not provide any
room for investigation of the factors influencing this ratio and evaluating the effectiveness
of risk management measures. Hence there is a need for a first principle driven transport
model of viruses (and potentially other pathogens) to understand their internalization in the
vasculature of plants.
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Understanding the risk posed by ARB has been stymied by the absence of DRMs parame-
terized for ARB. This difficulty arises from the clinical trials used to parameterize current
DRMs, which were performed using antibiotic sensitive bacteria (ASB). While we have in-
vitro kinetic information relating ARB to ASB, the biophysical/kinetic interpretation of
the parameters of the popular exponential and beta-Poisson DRMs is not straightforward.
Moreover, the dose-response outcome is potentially complicated by the other processes at
play, such as horizontal gene transfer and the differential influence of antibiotics on ASB and
ARB death rates. The resulting illness may or may not respond to antibiotic treatment if the
ARB subpopulation persists. These challenges require a mathematical framework capable
of handling the underlying processes, which can then be used to perform risk assessments of
ARB and determine the best course of action.
A point of longstanding debate in QMRA, and broadly the topic of disease progression, is the
hypothesis of independent action[57, 117, 93]. It proposes that pathogens act independently
of one another, and each has a probability p of initiating infection. The alternative hypothesis
is one of cooperation where infection is expected when more than one organism survives
to overwhelm the host’s defenses collectively. DRMs assuming independent action (also
called single hit models) have wider acceptance than DRMs which assume cooperativity (also
called multi-hit) [57]. However, DRMs with cooperativity consider the cumulative effects of
bacteria but not the potential synergistic interactions between bacterial cells or quorum
sensing. I believe that incorporating cell-cell interaction in dose-response is an essential step
to developing a better understanding of the development of disease and its treatment.
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Chapter 2
A transport model for quantifying
norovirus internalization in lettuce
The contents of this chapter appear in the journal Science of the Total Environment [25].
2.1 Background
The growth of the human population places an ever-increasing demand on freshwater re-
sources and food supply. The nexus of water and food is now well recognized. One promising
strategy to sustain food production in the face of competing water demands is to increase
the reuse of treated human wastewater. Municipal wastewater reuse for food production
has been successfully adopted in some regions of the world. For example, Israel uses 84%
treated wastewater in agriculture production [113]. However, Southern California, a region
that suffers from a similar degree of water shortage, currently uses less than 3% of municipal
wastewater in agriculture, while discharging 1.5 million acre-feet effluent per year into the
Pacific Ocean [59, 60]. Secondary municipal wastewater effluent for ocean discharge is often
6
sufficient to support both the nutrient and water needs for food production. Water reuse in
agriculture can bring municipal water reclamation effluent to nearby farms within the city
limit, thus promoting local agriculture and also reducing the rate of farmland loss to urban
development.
While the use of reclaimed water in agriculture offers a multitude of societal and agronomical
benefits, broader adoption faces great challenges. One of the important challenges is ensuring
the safety of food products in light of a plethora of human pathogens that may be present in
recycled wastewater. Past studies have identified risks associated with irrigating food with
recycled wastewater through the retention of the irrigation water on edible plant surfaces
during overhead irrigation [11, 58, 84, 89, 96, 119]. With the emphasis on water conservation
and reduction of transevaporation, subsurface drip irrigation is gaining popularity [132].
Since there is lesser contact between water and the plant surface, the chance of surface
contamination of pathogens is reduced. However, this new practice presents risk of uptake
of microbial pathogens into plants. Such internalized pathogens are of greater concerns as
washing, even with disinfectants, may not affect pathogens sheltered in the vasculature.
Although pathogen transport through root uptake and subsequent internalization into the
plant has been a growing research area, results vary due to differences in experimental design,
systems tested, and pathogens and crops examined [22, 35, 37, 62, 71, 111, 134, 141, 150].
Among the array of pathogens causing foodborne illness that may be carried by treated
wastewater, viruses are of the greatest concern but least studied. According to the CDC, 60%
of U.S. foodborne outbreaks associated with eating leafy greens were caused by noroviruses
(NoV), while Salmonella and E. coli only accounted for 10% of the outbreaks (http://www.
cdc.gov/features/norovirus/). Estimates of global foodborne illness prevalence associ-
ated with NoV ( 124 million) surpass all other pathogens considered [61]. Viruses are also
of concern because they persist in secondary wastewater effluents in high concentrations
[32, 42]. They do not settle well in sedimentation basins and are also more resistant to
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degradation than bacteria [145]. Therefore, in the absence of solid scientific understanding
of the risks involved, the public are likely less receptive to adopting treated wastewater for
agricultural irrigation.
NoV internalization in hydroponic systems has been quantified by [37]. Internalization in
crops grown in soil is considered lesser [141] but nevertheless occurs. However, the only risk
assessment [119] that considered the possibility of NoV internalization in plants assumed a
simple ratio of viruses in the feed water over viruses in produce at harvest to account for
internalization. The time dependence of viral loads in lettuce was not explored and such an
approach did not permit insights into the key factors influencing viral uptake in plants.
In this study, I introduce a viral transport model to predict the viral load in crisphead lettuce
at harvest given the viral load in the feed water. It is parameterized for both hydroponic and
soil systems. I demonstrate its utility by performing a quantitative microbial risk assessment
(QMRA). I explore strategies to reduce risk enabled by such a model, and use a sensitivity
analysis to identify influential factors that affect risk. (2.1)
# Description Equation Reference
Rate of change in viral conc (count cm−3 day−1)
2.1
Growth medium
(first-order
decay)
dC
dt
=
ηgrF (t)Cg(t)
Vg(t)
− kdecfCg(t) −
Cg(t)
Vg(t)
dVg(t)
dt
This work
2.2
Growth medium
(first-order
decay with
att-det)
dC
dt
=
ηgrF (t)Cg(t)
Vg(t)
− Cg(t)
Vg(t)
dVg(t)
dt
− (katt +
kdec)Cg(t) +
kdetNatt(t)
Vg(t)
"
2.3a Surface attached
dNatt(t)
dt
= kattCg(t)Vg(t)−(kdec+kdet)Natt(t) "
2.4 Root
dCro(t)
dt
=
ηgrF (t)Cg(t)
Vro(t)
− ηrsF (t)Cro(t)
Vro(t)
−
kpCro(t)− Cro(t)
Vro(t)
dVro(t)
dt
"
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2.5 Shoot
dCsh(t)
dt
=
ηrsF (t)Cro(t)
Vsh(t)
− kpCsh(t) −
Csh(t)
Vsh(t)
dVsh(t)
dt
2.6h
Hydroponic
viral transport
rate (cm3 day−1)
F (t) = at + bt
(
ρshootdshoot,h
dVsh(t)
dt
)
[28]
Growth rates (cm−3 day−1)
2.7h Root, hydro-ponic
dVro(t)
dt
=
exp(r1 + r2t+ r3t
2)
ρrootdroot,h
[17]
2.8h Shoot, hydro-ponic
dVsh(t)
dt
=
exp(s1 + s2t+ s3t
2)
ρshootdshoot,h
"
2.9s Shoot, soil dVsh(t)
dt
= rgVsh(t)
(
1− Vsh(t)ρshoot
wf
)
[129]
Others
2.10 Daily consump-tion λk = B × L× Csh(t)(tht)× ρ
−1
shoot This work
2.11 ApproximateBeta Poisson Pinf,k = 1−
(
1 +
λk
βB
)−αB
[136]
2.12 1F1 Hypergeo-metric Pinf,k = 1−1 F1(αH , αH + βH ,−λk) "
2.13 Fractional Pois-son Pinf,k = PF
(
1− exp(−λk
µa
)
))
"
2.14 Annual infectionRisk Pinf,ann = 1−
∏365
k=1(1− Pinf,k) [74]
2.15 Annual illnessRisk Pill,ann = Pill|infPinf,ann [89]
2.16 Annual diseaseburden Dannual = Pill|infPill,annDp "
2.17
Volume of
growth medium
(soil)
Vg,s = Veθ [29]
Table 2.1: Equations used in this study
a Units of (count day−1), h Specific to hydroponic model, s Specific to soil model
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Figure 2.1: Overview of model components (panel A) and information flow (panel B). Here
φ represents the null species. Symbols are defined in Table 2.2.
2.2 Methods
2.2.1 Model structure
To understand viral transport from treated human sewage to lettuce through internalization,
and the final viral concentration in the plant tissue at the time of consumption, I developed
a conceptual transport model (Fig. 2.1, symbols in Table 2.2).
In this system, I assumed that the treated wastewater used for cultivating lettuce is secondary
sewage effluent that contains Ceff of NoV/ml. Viral concentrations in the growth medium
(Cg,h(t) and Cg,s(t) for hydroponic and soil, respectively) at any given time are related
to the volume of the growth medium (Vg(t)) and the viral removal. Viral removal in the
hydroponic growth medium may be modeled simply as a first-order decay (eq. (2.1)) or also
to include attachment-detachment (AD) of viruses onto the walls of the hydroponic tank
(tank effects, eq. (2.2-2.3)). Similarly, I considered AD to soil particles as an important
process determining the fraction of viruses transferred from the soil to the plant roots. To
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avoid making assumptions on the tank geometry, I expressed the attached viral load in
viral numbers (Natt(t)), which does not depend on the volume or surface area. The viral
concentrations in the root (Cro(t)) and shoot (Csh(t)) depend on: 1) the viral transport rate
(F (t)) from the growth medium to the plant, 2) the volumes of these compartments (Vro(t)
and Vsh(t)), which change with time as the plant grows, and 3) the natural decay of viruses
in plant tissues. In addition, I included two viral transfer efficiencies (ηgr between growth
medium and root and ηrs between root and shoot) to simulate the potential “barrier” of viral
transfer between each compartment (Fig. 2.1).
Consequently, I modeled the viral transport from the growth medium to the root and shoot
through internalization as mass transport through three (growth medium, root and shoot)
well-mixed reactors (n − 1,n and n + 1) in series with changing volume. Thus, the generic
equation governing viral concentration (Cn(t)) in the reactor n at time t is:
Vn(t)
dCn(t)
dt
+ Cn(t)
dVn(t)
dt
= ηn−1,nF (t)Cn−1(t)− ηn,n+1F (t)Cn(t)− Removal(Cn(t))
where ηn,n+1 is the efficiency of viral transfer between reactors n and n+ 1. The full model
equations specific to individual model components are given by eq. (2.1-2.9) in Table 2.1
and used for both soil and hydroponic systems. Finally, I estimated the health risk from the
consumption of shoot of lettuce irrigated by recycled wastewater (Fig. 2.1).
2.2.2 Model parameters to estimate viral transport in lettuce
I obtained some parameters to complete the conceptual viral transport model from the
literature. I estimated the remaining by fitting the model to published data from experiments
using NoV seeded feed water to grow crisphead lettuces in a hydroponic system [37]. I
adopted the initial volume of 800 mL for the hydroponic growth medium (Vg,h(0)) based
on these experiments. I also assumed that the volume reduction over time equivalent to
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the plant transpiration rate [28] between refills. For the soil system, the volume of the
growth medium (Vg,s) equals the volume of water contained in the soil interstitial spaces in
an envelope around the roots. I assumed that this envelope is a region (of volume Ve) around
the roots that the plant to interact with. Vg,sis given by eq. 17, where θ is the volumetric
water content obtained from [29]. Estimates for Ve spanned a large range (section A.2.1)
and I adopted a middle value of Ve = 80000 cm3 and assumed it to be constant over the
lettuce growth period. I also verified that this assumed value wasto have minimal impact on
the model outcome (see section 2.2.5 and section 2.3.2).
I adopted the plant transpiration rate as the viral transport rate (F (t)) based on: 1) previ-
ous reports of passive bacterial transport in plants [13, 138, 146], 2) the significantly smaller
size of viruses compared to bacteria, and 3) the lack of known specific interactions between
human viruses and plant hosts (section A.1.1). Accordingly, I determined the viral transport
rate in hydroponically grown lettuce (eq. (2.6)) from the previously reported transpiration
model [28], in which the transpiration rate is proportional to the lettuce growth rate and
is influenced by cultivar specific factors (at,bt). I predicted these cultivar specific factors
using the hydroponic crisphead lettuce growth experiment carried out by [37] described in
section 2.2.3 (and section A.1.4). Since the transpiration rate in soil grown lettuce is signifi-
cantly higher than that in the hydroponic system, I obtained the viral transport rate in soil
grown lettuce from the graphs published by [45] using WebPlotDigitizer [115] section A.2.3
for details).
I estimated the growth rates of lettuce root (dVro(t)/dt) and shoot (Vsh(t)/dt) in hydroponic
systems using eq. (2.7-2.8) (parameters in Table 2.2; details and assumptions in section A.1.2
and section A.1.3). For soil grown lettuce, I determined the the shoot growth rate (in terms
of fresh volume) using eq. (2.9) (parameters in Table 2.2; details in section A.2.2). In the
absence of a published root growth model for lettuce in soil, I used a fixed root volume of
100 cm3.
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Parameter Symbol Value/Distribution (Units) Reference
Common (soil+hydroponic)
Body weight+ B [67.0 (10.7, 113.9)] (kg
person−1)
[73]
Viral load in effluent+ Ceff [4.13 (0.04, 624.32)] (count
mL−1)
[85]
Concentration of virus
in growth medium (root,
shoot) *
Cg(t)
(Cro(t),
Csh(t))
Cg,s(0) = Cg,h(0) = Ceff
(count mL−1)
DALYs per case of NoV
GE
Dp 9× 10−4 (person−1year−1) [75]
Volumetric flow rate* F (t) Fh(t) from eq. (2.6), Fs(t)
from plot (mL day−1)
[16, 45]
Growth medium viral at-
tachment rate*
katt katt,s(S1,S2)=4.1,0.8; katt,h
[f] (day −1)
[121]
Growth medium vi-
ral decay rate (with
attachment-detachment)
*
kdec kdec,s=0.15; kdec,h [f] (day
−1)
[114]
Growth medium viral de-
cay rate (only first-order
decay)
kdecf(t) [f] (day−1)
Growth medium viral de-
tachment rate*
kdet kdet,s(t) (S1,S2)= 8.7 ×
10−4, 3.0× 10−3; kdet,h(t) [f]
(day−1)
[121]
Viral decay constant in
plant (root, shoot)
kp [f] (day−1)
Consumption of lettuce
per kg bodyweight+
L [0.38, (0.04, 2.08)] (g lettuce
kg−1person−1day−1)
[135]
Number of viruses at-
tached to growth medium
Natt(t) Model intermediate (count)
Probability of illness if in-
fected
Pill|inf 0.8 [95]
Last irrigation time* tli tli,h = 21tli,s = 56 (days) [16, 45]
Harvest time* tht tht,h = 35, tht,s = 70 (days) "
Volume of growth medium
(root, shoot) *
Vg(t)
(Vro(t),
Vsh(t))
Vg,h(0)=800 mL Vro,s=100
Fractional Poisson risk
model parameters
PF, µa 0.72, 1 [136]
Beta Poisson risk model
parameters
αB, βB 0.104, 32.3
Hypergeometric risk
model parameters
αH, βH 0.46, 1.20
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Shoot density ρshoot 0.35 (g cm−3) [72]
Hydroponic specific
Rate parameters for viral
transport by plant
at,bt [f] (mL day−1, mL)
Ratio of dry to fresh
weight of lettuce root
droot,h 0.057 Estimated
from [152]
Ratio of dry to fresh
weight of lettuce shoot
dshoot,h 0.045 [16, 28]
Root growth constants r1 -8.482 "
r2 0.4586 (day−1) "
r3 −6.472× 10−3 (day−2) "
Shoot growth constants s1 -7.414 "
s2 0.406 (day−1) "
s3 −5.579× 10−3 (day−2) "
Root density ρroot 0.2 g cm−3 Assumed
Soil specific
Shoot growth constant rg 0.2056 (day−1) [128]
Envelope volume Ve 80000 (cm3) Assumed
Final weight of lettuce wf 550 (gm) [72]
Volumetric water content
of soil
θ 0.435 [29]
Table 2.2: Summary of symbols and parameter values
*: These are represented by their subscripts (h: hydroponic, s: soil) where required; +:
Empirical distributions, values presented are median (95% interval); [f]: Fitted values, pre-
sented in Table 2.3
Additionally, I used a viral transfer efficiency (η) to account for the potential “barrier”
between each compartment (i.e. root and shoot). The existence of such a “barrier” is evident
from field experiments where some microbial pathogens were internalized in the root but not
in the shoot of plants [102]. In addition, viral transfer efficiencies (ranging from 0 – 1) also
account for differing observations in pathogen internalization due to the type of pathogen or
lettuce. For example, [37] reported the internalization of NoV into lettuce, while [134] did
not detect any NoV in another type of lettuce grown in feed water seeded with viruses. I
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determined the values of ηgr and ηrs by fitting the model to experimental data reported by
[37] (details in section 2.2.3). I assumed that the values of ηgr and ηrs for the soil case was
the same as predicted for the hydroponic lettuce.
I included both die-off and AD for viral removal in the growth medium, but only natural
die-off in the lettuce root and shoot. I obtained the AD kinetic constants (katt, kdet) as
well as the growth medium viral decay constant (kdec) in the hydroponic case by fitting the
model to the data from DiCaprio et al. (2012). Viral AD in soil has been investigated
in both lab scale soil columns and field studies (Schijven and Hassanizadeh, 2000). In my
model, I obtained viral AD constants (katt,s , kdet,s) in soil from the experiments of [121], who
investigated MS2 phage kinetics in sandy soil in field experiments. As the MS2 phage was
transported with the water in soil, the AD rates changed with the distance from the source
of viruses. To capture the range of AD rates, I investigated two scenarios of viral behavior
in soils. Scenario 1 (Sc1) used the AD rates estimated at the site closest to the viral source
(well 1), while scenario 2 (Sc2) used data from the farthest site (well 6). In contrast to
lab scale soil column studies, field studies provide more realistic viral removal rates [120]. I
used the surrogate phage MS2 for NoV as it provided conservative risk estimates, since MS2
attached to a lesser extent than NoV in several soil types [91]. I adopted the viral decay rate
in the soil (kdec,s(t)) determined by [114] because the experimental temperature (20-30 0C)
and soil type (clay loam) are more relevant to lettuce growing conditions compared to the
other decay study [121]. I used the decay rates in the root and shoot from the hydroponic
system predictions.
2.2.3 Fitting model of viral transport in hydroponic grown lettuce
I fitted the transport model to log10 viral concentration data from [37], extracted from graphs
therein using WebPlotDigitizer [115]. In these experiments, NoV of a known concentration
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Parameter Units Search bounds Median (95% Credible Interval)
at cm3 day−1 (0,100) 19.82 (0.71,39.92)
bt cm3 g−1 (0,300) 40.10 (1.19,96.96)
ηgr - (0,1) 0.48 (0.07,0.97)
ηrs - (0,1) 0.74 (0.24,0.99)
katt day−1 (0,20) 10.66 (0.62,19.55)
kdet day−1 (0,10) 5.19 (0.65,9.76)
kdec day−1 (0,100) 0.25 (0.03,0.54)
kp day−1 (0,20) 0.54 (0.02,6.29)
Table 2.3: Parameter values predicted from fitting model to data from hydroponic experi-
ments
was spiked in the feed water (growth medium) of hydroponic lettuce and was monitored in
the feed water, the root and shoot over time. While fitting the model, I adopted an initial
feed volume of 800 mL (as used in the experiments) and rejected parameters producing final
volumes of <200 mL.
To fit the model while accounting for uncertainty in the data, I used a Bayesian approach to
maximize the likelihood of the data given the parameters. I obtained a posterior distribution
of the parameters by the differential evolution Markov chain (DE-MC) [130] algorithm, which
can be parallelized and can handle multimodality of the posteriors distribution without fine
tuning the jumping distribution. I carried out the computation on the High Performance
Computing facility at UC Irvine, using MATLAB R2016a (Mathworks) and its ParComp-
Tool.
Table 2.3 lists the parameters estimated by model fitting and their search bounds. Fitting
data from [37] without including viral AD to the tank walls was attempted but the results
were not used in the risk estimates due to the poor fit of model to the data. The rationale
behind the model fitting procedure and diagnostics are discussed in section A.2.4.
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2.2.4 Estimating risk of consumption of lettuce
I used an empirical distribution for NoV in activated sludge treated secondary effluent [85]
to obtain the viral concentration (Ceff) in the irrigation water. As justified by [85], I used
the sum of the concentrations of two genotypes known to cause illness to construct the
distribution. I then estimated the NoV concentrations in lettuce shoot at typical harvest
times: tht,h(t)=35 days in the hydroponic system and tht,s(t)=70 days in soil. I also assumed
that the last irrigation with recycled water occurred on tli,h(t)=21 days for hydroponic and
tli,s(t)=56 days for soil grown lettuce. I used these values together with parameters in
Table 2.2 and Table 2.3 in eq. (2.1-2.9) (Table 2.1) to generate the probability distribution
of NoV concentration for hydroponic or soil grown lettuce.
To estimate the risk from consumption of lettuce, I computed the daily viral dose using
eq. (2.10) (Table 2.1) for the kthday. I sampled the body weight (B) from an empirical
distribution for all ages and genders in the United States, which I constructed from a report
of the percentile data of body weight. I sampled the lettuce consumption rate (L) from
an empirical distribution which I constructed from data reported by the Continuing Survey
of Food Intakes by Individuals (CSFII). I used the ‘consumer only’ data for all ages and
genders, and hence the reported risk is only for those who consume lettuce. It is important
to note that the daily viral dose was computed in (count g−1) from the model output (in
count mL−1) using the shoot density ρshoot(eq. (2.10)) to be consistent with the consumption
rate reported in CSFII.
Several different NoV dose-response models have been proposed based on limited clinical
data. The validity of these models is a matter of much debate [122, 136], which is beyond
the scope of this study. These models differ in their assumptions resulting in large variability
of predicted risk outcomes. To cover the range of potential outcomes of human exposure to
NoV, I estimated and compared risk outcomes using three models: 1) Approximate Beta-
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Poisson (BP) [131, 136]; 2) Hypergeometric (1F1) [4, 10, 131] ; and 3) Fractional Poisson (FP)
[92]. In the risk estimation, I considered NoV in the lettuce tissue exists as individual viral
particles (disaggregated form) and used the disaggregated NoV models. The model equations
are given by eq. (2.11-2.13), Table 2.1. I calculated ten thousand samples of the daily
infectious risks from BP and FP models using MATLAB R2016a. Wolfram Mathematica
11.1 (Wolfram Research) was used for the (1F1) model estimation as it was faster.
Using a random set of 365 daily risk estimates of (Pinf,k for day k), I calculated the annual
infection risk (Pinf,ann) according to the Gold Standard estimator [74] using eq. (2.14),
Table 2.1. While there appears to be some dose dependence for illness resulting from infection
Pill|inf[10, 131], this has not been clearly elucidated for the different dose-response models.
Hence, I adopted the procedure used in [89] and calculated annual illness risk with eq. (2.15).
The annual disease burden in terms of DALY (disability adjusted life years) lost per case
(Dp) was set to 9× 10−4 pppy for each case of NoV disease [75]. The annual disease burden
(Dannual) is given by eq. 16 in Table 2.1. As part of the risk characterization process, I
compared risk outcomes of this study to the acceptable risk benchmarks established by the
U.S. EPA and WHO and the estimates by [119].
2.2.5 Sensitivity analysis
I determined the global sensitivity of the log10(Pinf) (daily risk) to input parameters using
the SCSA method [83] since it accounts for correlation in input parameters (not handled by
Sobol’s method [125]). This method produces three sensitivity indices for each parameter,
the structural (Sstruct), correlative (Scorr) and total (Stot) sensitivities. Fitted parameters
were used as is, maintaining the observed correlation structures. Parameters drawn from
distributions were varied within their 95% credible intervals while other parameters spanned
ranges obtained from literature (section A.2.5). The MATLAB implementation of SCSA by
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Figure 2.2: Fit of the model to data from [37] for lettuce grown in hydroponic system. Top
panel shows model fitting using first-order viral decay only; bottom panel shows model fitting
using first-order viral decay and viral attachment/detachment (AD) to cultivation tank wall
in growth medium (water). Error bars indicate standard deviations of 3 samples.
Sahin and Vrugt [118] was used.
2.3 Results
2.3.1 Model fitting and parameter prediction
Fig. 2.4 shows a summary of the model fitting exercise for viral transport in hydroponic
grown lettuce. Under the assumption of first-order viral decay, NoV loads in water (growth
medium) at two time-points did not fall in the credible region of model predictions, indicating
that mere first-order decay was unsuitable to capture the observed viral concentration data.
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Figure 2.3: Illustration of joint distributions of posterior samples from fitting the model
with AD of viruses to hydroponic tank walls. The shaded gradients (light to dark) indicate
the localization of parameters in sub-regions of the initial search space, illustrating coupling
between the parameters.
The addition of the AD factor into the model addressed this inadequacy and importantly
supported the curvature observed in the experimental data. This result indicates the AD of
viruses to hydroponic tank wall is an important factor to include in predicting viral concen-
tration in all three compartments (water, root, shoot). Credible and prediction intervals in
the shoot at harvest were similar for both models.
The credible intervals of the predicted parameters also show the adequacy of fit for the model
with AD (Table 2.3). Four of the predicted parameters: at,bt,kdec,s and kp, were restricted
to a smaller subset of the search bounds, indicating that they were identifiable. In contrast,
the viral transfer efficiency η and the kinetic parameters (katt,kdet) spanned the entirety of
their search space and were poorly identifiable. However, this does not suggest that each
parameter can independently take any value in its range because the joint distributions of
the parameters (Fig. 2.3) indicate how fixing one parameter (e.g. ηgr=0.9) influences the
likelihood of another parameter (ηrs most likely to be closer to 1). Hence, despite the large
range of an individual parameter, the coordination between the parameters constrained the
model predictions to produce reliable outcomes (section 2.4.1, Fig. A.5). Hence, I consider the
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Figure 2.4: Annual risk (top panel) and disease burden (bottom panel) of norovirus in-
fection through consumption of lettuce grown hydroponically or in soil (scenario 1 and 2
explained in section 2.2.2) using treated sewage effluent. The dashed lines indicate existing
risk benchmarks or the mean plotted from a previous study by [119].
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Figure 2.5: Top 10 most significant SCSA sensitivity indices (mean±s.d., 100 bootstrapped
samples) for hydroponic (top panel) and soil (bottom panel) grown lettuce. Sstruct, Scorr and
Stot correspond to Sa, Sb and S in [83]. A comma denotes second order sensitivity terms for
pairs of parameters.
performance of the model with AD adequate for estimating parameters used it for predicting
risk.
2.3.2 Health risks from lettuce consumption
Risk estimates for lettuce grown in the hydroponic tank or soil are presented in Fig. 2.4.
Across these systems, the FP model predicted the highest risk while the 1F1 model predicted
the lowest risk. For a given risk model, higher risk was predicted in the hydroponic system
than in the soil. This is a consequence of the very low detachment rates in soil compared to
the attachment rates. Comparison of results from Sc1 and Sc2 (section 2.2.2) of soil grown
lettuce indicated lower risks and disease burdens under Sc1 (Fig. 2.4).
Comparing with the safety guidelines, the lowest risk predicted in the hydroponic system is
higher than the U.S. EPA defined acceptable annual drinking water risk of 10−4 (Environ-
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mental Protection Agency, 2010) for each risk model. The annual burdens are also above the
10−6 benchmark recommended by the WHO [143]. In the case of soil grown lettuce, neither
Sc1 nor Sc2 met the U.S. EPA safety benchmark. Two risk models predicted borderline
disease burden according to the WHO benchmark, for soil grown lettuce in Sc1, but under
Sc2 the risk still did not meet the safety guideline. I found that neither increasing holding
time of the lettuce to two days after harvesting nor using bigger tanks significantly altered
the predicted risk (Fig. A.1). In comparison, the risk estimates of [119] are higher than range
of soil grown lettuce outcomes presented here (Fig. 2.4) for 2 of 3 models.
The SCSA sensitivity indices are presented in Fig. 2.5. For hydroponically grown lettuce, the
top 3 factors (by Stot) influencing daily risk are amount of lettuce consumed, time since last
irrigation and the term involving consumption and ρshoot. Also, the risk estimates are robust
to the fitted parameters (Table 2.3) despite low identifiability of some model parameters (at,
bt, katt,h and kdet,h ). For soil grown lettuce, kp appears to be the major influential parameter,
followed by the input viral concentration in irrigation water and the lettuce harvest time.
Scorr is near zero, suggesting lesser influence of correlation in the input parameters.
2.4 Discussion
In this study, I modeled the internalization and transport of NoV from irrigation water to
the lettuce using ordinary differential equations to capture the dynamic processes of viral
transport in lettuce. This first attempt is aimed at underscoring the importance of the
effect of time in determining the final risk outcome. The modeling approach from this study
may be customized for other scenarios for the management of water reuse practices and for
developing new guidelines for food safety. Moreover, this study identifies critical gaps in the
current knowledge of pathogen transport in plants and calls for further lab and field studies
to better understand risk of water reuse.
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2.4.1 Fitting model to data
To predict viral transport in plant tissue, it is necessary to couple mathematical assumptions
with an understanding of the underlying biogeochemical processes governing virus removal,
plant growth, growth conditions and virus-plant interactions. For example, although a simple
transport model without AD could predict the viral load in the lettuce at harvest, it failed to
capture the initial curvature in the viral load in the growth medium (water). An alternative
to the AD hypothesis that could capture this curvature is the existence of two populations
of viruses as used in [104], one decaying slower than the other. However, I did not adopt this
approach as the double exponential model is not time invariant. This means that the time
taken to decay from a concentration C1 to C2 is not unique and depends on the history of the
events that occurred (Fig. A.2). Other viral models, such as the ones used in [103] faced the
same issues. Incorporating AD made the model time invariant and always provided the same
time for decay between two given concentrations. This model fitting experience showcases
how mathematics can guide the understanding of biological mechanisms. The hypothesis of
two different NoV populations is less plausible than that of viral attachment and detachment
to the hydroponic tank. While it appears that incorporating the AD mechanism does not
significantly improve the accuracy of viral load predictions in the lettuce shoot at harvest, this
is a consequence of force fitting the model to data under the given conditions. Changing the
conditions, for example, by reducing viral attachment rate to the tank wall, underestimates
the viral load in the lettuce shoot in the absence of AD (Fig. A.3). I believe that the model
can be improved significantly with new insights on virus-plant interactions.
A potential cause for concern in the model fit is the wide credible and prediction intervals.
However, there is significant uncertainty in the data as well (e.g. root day 3, shoot day 1,
Fig. 2.4) suggesting that the transport process itself is noise prone. Moreover, from the per-
spective of risk assessment, the variability between dose-response models is higher than the
within dose-response model variability (Fig. A.5). Since within dose-response model variabil-
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ity stems from uncertainty in viral loads at harvest among other factors, the wide intervals
do not exert a bigger effect than the discordance from different dose-response models.
2.4.2 Model parameter estimates
Some parameters (i.e., kdec,h, kp) are identifiable to a reasonable degree through model fitting,
but there is a large degree of uncertainty in the viral transport efficiencies and the AD kinetic
parameters. While this could be a consequence of fitting a limited number of data points with
several parameters, the viral load at harvest and risk estimates were well constrained. This
large variation in parameters and ‘usefully tight quantitative predictions’ (Fig. A.5) is termed
the sloppiness of parameter sensitivities, and has been observed in physics and systems
biology [55, 139]. Well-designed experiments may simultaneously reduce uncertainty in the
parameters as well as predictions [6, 24] and therefore increasing confidence in predictions.
One possible experiment to reduce parameter uncertainty is recording the transpiration and
growth rate to fit eq. (2.6) independently to get at and bt.
2.4.3 Risk estimates
An interesting outcome of my analysis is the strong association of risk with plant growth
conditions. The health risks from consuming lettuce irrigated with recycled wastewater
are highest in hydroponic grown lettuce, followed by soil grown lettuce under Sc2 and the
least in soil grown lettuce under Sc1 (Fig. 2.4 and section 2.2.2). This difference in risk
estimates stems to a large degree from the difference in AD kinetic constants (katt,s, kdet,s)
(Fig. A.4). Increasing katt,s (holding kdet,s constant) will decrease risk as more viruses will
get attached to the growth medium, while increasing kdet,s (holding katt,s constant) will have
the opposite effect (Fig. A.4), as more detached viruses are available for uptake by the plant.
The combined effect of the AD parameters depends on their magnitudes and is portrayed
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in Fig. A.4. This result indicates that a better understanding of the virus interaction with
the growth environment can lead to an improved understanding of risk. More importantly,
this outcome indicates that soil plays a vital role in the removal of viruses from irrigation
water through the adsorption of viral particles. An investigation focused on understanding
the influence of soil composition on viral attachment will help refine the transport model.
The risk predicted by this dynamic transport model is higher than the EPA annual infection
risk as well as the WHO annual disease burden benchmark. The reasons for this outcome are
many-fold. First, there is a significant variability in the reported internalization of viruses
in plants. In research of data for modeling NoV transport in plant, I filtered the existing
data using the following criteria: 1) human NoV used as the seed agent, 2) presence of
quantitative viral results in the growth medium and different locations of the plant. Based
on these criteria, the data from [37] represent the best available data on viral internalization
and transport in lettuce. However, it is also important to note that a similar study by [134]
did not observe human NoV internalization in lettuce. This discrepancy could be due to the
specific subspecies of the plant and growth conditions used in the studies. Besides, minor
changes such as damages in roots or decrease in humidity of the growing environment can
promote pathogen internalization [62, 137]. Alternatively, tracking viral transport through
the growth medium and the plant is challenging, which may yield false results due to reaction
inhibitions in genome amplification and inferior detection limit.
The risk outcome of this study is conservative because it assumes an individual consumes
the wastewater irrigated lettuce daily for an entire year. This assumption and the corre-
sponding higher risk estimates are only applicable to a small portion of consumers, while
most consumers in the U.S. are likely to have a more diverse diet. While the model outcomes
presented here represent the best attempt given the available data, it is also possible that the
internalization observed by [37] is an extreme case and and typically internalization occurs
to a lesser extent.
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As previously discussed by others ([122, 136]), risk estimates by different NoV dose-response
models differed by orders of magnitude. This study primarily aims to introduce a viral
transport model without advocating any one dose-response model. The future refinement of
pathogen dose-response models will reduce variability in risk estimates.
The risk of consuming lettuce grown in soil as predicted by [119] is higher than my pre-
dictions, although I used the results of [37] in both studies. This is a consequence of con-
sidering the greater adsorption capability of soil, which is not reflected when assuming a
simple input:output ratio. Using different inoculating concentrations of NoV, body weight
and consumption rate distributions also contributed to the difference in the outcomes but
to a lesser extent.
I obtained parameters for crisphead lettuce from several different sources, each possibly
using a different sub-variety of crisphead. Nevertheless, global sensitivity analysis showed
insensitivity of risk estimates to several assumed and fitted parameters (at, bt, droot,h,Ve),
lending confidence to the approaches taken to parametrize the model. The sensitivity to tli,h
in hydroponic and tht,s in soil cases underscores the importance of considering the dynamics
of viral transport. This suggests that given no change in lettuce consumption, changes
in irrigation schedule can affect risk outcomes. Such arguments are not possible with the
approach of [119]. In soil-grown lettuce, the high sensitivity to kp indicates the role of
plant-specific processes in mediating risk outcomes.
2.4.4 Contribution and future directions
In addition to a transport model predicting the NoV load in lettuce, I explored strategies to
reduce the risk of NoV gastroenteritis (Fig. A.1) by increasing holding time of the produce
after harvesting or using larger hydroponic culture volumes. Although neither strategy
could significantly alleviate the risks, the process highlights two strengths of modeling: 1)
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It provides analytical support for arguments that would otherwise be less convincing; 2) It
predicts outcomes of experiments without the physical resources required to perform them.
For instance, the model can be used to explore alternate irrigation schedules to reduce the
NoV internalization risk.
Modeling also helps encapsulate our understanding of the system and generate hypotheses.
For example, simple first-order decay did not produce the trend observed in the water,
which suggests that additional mechanisms are at play. I postulated the attachment of virus
particles on the walls of the hydroponic system as one possible mechanism and examined the
fit of the model. Although viral attachment to glass or other materials has been observed
before [15], here it stands as a hypothesis that can be tested. In addition to generating
and testing hypotheses, some of my model assumptions raise broader questions for future
research. For example, I assumed that viruses are transported at the transpiration rate from
the growth medium to the roots. However, not much is known regarding the role of roots
in the internalization of viruses. Investigating the defense mechanisms of plants’ roots to
passive viral transport, i.e., through rhizosphere microbiome interactions, may shed light on
the broad understanding of plant and microbe interactions.
The question of extending this model to other pathogen and plant systems draws attention
to the dearth of data in enabling such efforts. While modeling another virus may not require
changes to the model, understanding transport in other plants can be challenging. Data
required includes models for growth rate and transpiration, plant growth characteristics
including density, water content, as well as internalization studies to determine transport
efficiencies. However, from the perspective of risk management, lettuce may be used as
the worst-case scenario estimate of risk in water reuse owing to its high consumption with
minimal pathogen inactivation by cooking. This worst-case scenario can be used to set
water quality standards for irrigation water for the production of fresh produce eaten raw.
The models can also be extended to include pathogen transport to the plant tissue from
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manure/biosolids that are used as organic fertilizer.
2.5 Conclusion
I developed a dynamic viral transport model to predict the viral load in the lettuce at harvest,
given the viral load in the recycled water used for irrigation. Integrating the viral load with
the exposure model and NoV dose-response models, I estimated the annual infection risk
and disease burden through the consumption of lettuce irrigated with recycled wastewater.
My conclusions are:
1. Viral transport in the plant depends on its interaction with the growth medium and
the plant tissue to a large extent.
2. The experimental data reported in literature are best explained by the incorporation
of attachment and detachment of the viruses to the cultivation tank.
3. Kinetic rates for attachment and detachment, as well as transport efficiencies between
plant compartments, were loosely constrained in their search bounds (low identifiabil-
ity). However, the joint distributions of the parameters and the final risk predictions
were well constrained, highlighting the sloppy parameter sensitivities.
4. The overall risk estimates from the model are higher than the commonly accepted infec-
tion risk benchmark and annual disease burden. However, there are large uncertainties
in the experimental data of viral transport through plants.
5. The model provides a foundation to incorporate new data on pathogen transport and
plant-microbe interactions to develop a holistic understanding of pathogen internaliza-
tion.
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Chapter 3
Quantifying the infection risk of
antibiotic-resistant bacteria
The contents of this chapter appear in the journal Scientific Reports [26].
3.1 Background
The rise of antibiotic resistance in bacteria, coupled with the slowdown of drug discovery,
presents a growing threat to public health [144]. The Centre for Disease Control and Pre-
vention (CDC) attributes at least 2 million illnesses and 23,000 deaths a year in the US to
antimicrobial resistance. The economic burden in the US is estimated to be on the order of
US $21 to $34 billion [23].
Quantifying the human health risk associated with antibiotic resistance presents several
challenges [8, 14, 43, 65, 108, 101, 88]. The human health outcome (e.g., illness not responding
to a specific antibiotic or ‘resistant’ illness) is influenced by antibiotic-resistant bacteria
(ARB), antibiotics (ABs), antibiotic-resistant genes (ARG) and their carriers. ARB cause
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antibiotic-resistant illness and present the most direct threat. Antibiotics and other selective
pressures (e.g., heavy metals) in the environment promote enrichment of ARB and induce
de-novo resistance mutations in antibiotic susceptible bacteria (ASB) or the uptake of ARG
which is known as horizontal gene transfer (HGT). The ARG can come from direct contact
with bacteria harboring ARG (conjugation), from phages harboring ARG (transduction)
or from free-floating mobile genetic elements (MGEs) in the environment (transformation).
ABs in the environment can potentially modulate HGT. Thus the human health outcome
from ingesting ARB can be influenced by a complex network of factors.
Studies have found ARB in various sources across the globe, including wastewater treatment
plant effluent, recreational water, drinking water (see [101] for a list), and even lettuce at
harvest [64]. Nevertheless, microbial risk assessments involving ARB are rare [47, 124],
which is due to the lack of a dose-response model (DRM) and uncertainties at each step
in a traditional bottom-up risk assessment approach. Few past studies (e.g., [41, 148])
investigated the burden of ARB using a top-down approach by identifying the contribution
of veterinary AB use to the overall number of AB resistant disease instances [124]. However,
this top-down framework cannot be used to compute the risk posed by an exposure event
(such as swimming in the recreational waters discussed in [82]), nor can it be used to set
regulatory guidelines for acceptable levels of ARB or residual ABs in the environment.
Attempts to relate ARB concentrations to ARB caused diseases (bottom-up approach) were
made in several studies [5, 30, 68, 107]. Since DRMs tailored to ARB do not exist, these
studies draw on epidemiological data (e.g., annual illness cases where some AB fails) to
predict human health effects. However, there is a large variability of the estimates depending
on the scope and geographic region of the investigation. These past studies are useful to draw
inferences on the region that the data are based on but may not apply to other regions e.g.,
resource-limited countries where epidemiological data are not available. Moreover, even if
data are available, avoiding confounders to pinpoint the true cause of an antibiotic-resistant
31
illness is non-trivial. Also, these approaches cannot account for the fraction (fr) of ARB in
a bacteria-contaminated sample or the effects of residual ABs in the environment. Hence,
there is a need for DRMs that can account for ARB [82, 101], their fraction (fr) in the dose
and residual ABs.
Obtaining data to develop a DRM for human illness involves infecting a cohort of people with
a known pathogen, including AB resistant ones. However, since inoculating people with ARB
would result in untreatable illnesses, such data are not available. An alternative approach
is to use the existing data collected from human studies involving ASB and assume that
in the absence of AB, the same DRM used for the ASB applies to ARB. This assumption
is conservative since AB resistance often confers a fitness cost [153]. Some studies have
identified mutations that lead to increased fitness have [12, 54]. While data from animal
models present a second alternative, usage of human data, where available, is preferred.
The development of DRM for ARB is further complicated when the person under considera-
tion is exposed to residual/sub-inhibitory levels of ABs. This exposure can stem from medi-
cation for a previous illness, prophylactic use for surgeries, receiving AB-releasing stents, AB
residues in food of animal origin, or even the environmental sources listed earlier. The source
of ARB could also contain AB, causing the host to get exposed to sub-inhibitory levels of
AB. In this case, the health outcome (not ill, AB treatable illness, or AB untreatable illness)
will depend on not only the initial dose (d) and fraction of ARB (fr), but also the amount
of residual AB. This is because the AB will affect the growth rates of the susceptible and
resistant subpopulations differently in a concentration-dependent manner. Popular/classical
microbial pathogen DRMs, such as the exponential or beta-Poisson models, are not readily
amenable to investigation of such changes in growth rates or conversion from ASB to ARB
due to mutation or HGT. Hence there is a need for DRMs based on growth processes, which
can set the stage for developing a holistic understanding of the dose-response of ARB.
The goal of this research is to quantify the risk posed by ARB and the effect of selection
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pressure exerted by sub-inhibitory concentrations of AB. Specifically, I introduce a new
DRM based on Simple Death processes. This DRM begins with the following assumptions:
1) a portion of ingested dose of d bacteria may die off (solid lines, Fig. 3.1a) when they
encounter the host’s defenses. This includes immune factors, gastric acids, and other fac-
tors. 2) At greater d, this death rate may not be enough to kill off all the bacteria. In
some cases, enough bacteria survive to initiate an infection (Trial 2, Fig. 3.1a), resulting
in growth (dotted line, Fig. 3.1a) of bacteria in human body (infection). I model these
two assumptions with continuous-time Markov chains (CTMCs) to capture stochastic bac-
terial kinetics. This differs from existing approaches which derive kinetics from classical
dose-response assumptions[67] or which use deterministic kinetics to inform dose-response
[90, 112]. My approach is similar to the approaches of [109, 147, 49] and other studies that
use CTMCs, but uses analytical solutions instead of simulations. Another study [18] explores
an analytical approach specific to anthrax and uses in vivo animal data to fit parameters.
However, it is not clear if the parameters found in animals apply to humans. Here, I show
that my approach integrates with classical DRMs and can hence extend to all pathogens
analyzed with the classical DRM framework.
Figure 3.1: Overview of simple death process. (a) Plots of two trials of a simple death
process. (b) The Markov chain of a simple death process.
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This study is organized as follows. I introduce the new DRM and fit it to published dose-
response data of AB susceptible E. coli that causes diarrhea. I then identify a relationship
between the kinetic constants in the proposed model and the existing DRMs. I use this
relationship to predict the risk of illness and the illness subtype (AB treatable vs. AB
untreatable) for mixed doses of ARB and ASB in the presence of residual AB. Finally, I
highlight the limitations of this approach and the need for improved data collection comple-
menting this approach. Parameters and their symbols presented in this chapter are listed in
Table 3.1.
Symbol Units Description
C mg L−1 AB concentration
d CFU Dose of bacteria
Emax, EC50 day−1, mg L−1 AB-bacteria interaction parameters
fr - Fraction of ARB in initial dose
nill persons Number of ill subjects
ntot persons Total number of subjects
P (d, t) - Response probability for initial bacterial load of d at t
Pext(d, t) - Probability of extinction of initial bacterial load of d at t
P (d) - Response probability for initial bacterial load of d
r CFU−1 Exponential DRM parameter
t days Time
tfs days The latest time at which a first symptom is observed
α, β -, CFU beta-Poisson DRM parameters
µ day−1 Death rate of bacteria
µs,AB(C) day−1 Death rate of ASB in AB of concentration C
µr,AB(C) day−1 Death rate of ARB in AB of concentration C
Table 3.1: Parameters used in this study.
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3.2 Results
3.2.1 Dose-response expression
I model the initial die-off of the bacteria after they enter the host as a stochastic death
process, which is a kind of CTMC. In such a process, a single death is assumed to occur
at a random point in time (solid lines, Fig. 3.1a). The key assumption behind the Simple
Death (SD) process (Fig. 3.1b) is that in the short time interval (t, t + δt), each bacterium
dies with probability µδt. Hence, the probability of a death in the time interval (t, t + δt)
is N(t)µδt, where N(t) is the population size at time t. As time goes by, N(t) will reduce
as some bacteria begin to die, thus decreasing the probability of a death in the time interval
(t, t + δt). Assuming that the probability of observing a response (here illness) equals the
probability of not observing an extinction, I express the relation with eq. 3.1.
P (d, t) = 1− Pext(d, t) (3.1)
where P (d, t) is the probability of observing a response and Pext(d, t) is the probability of
extinction for initial dose d and time t. The expression for Pext(d, t) [3] is given by
Pext(d, t) = (1− exp(−µt))d (3.2)
Intuitively, 1−exp (−µt) is the probability of the death of one bacterium [3]. The probability
of d bacteria dying is the product of the probability of each bacterium dying, resulting in
eq. 3.2. Therefore, I express the time-dependent dose-response relationship or the time-
dependent SD DRM as:
P (d, t) = 1− (1− exp(−µt))d (3.3)
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I set t in the model (eq. 3.3) to the latest time that the first symptom is observed among all
subjects (tfs) in the clinical feeding study. This is because at t < tfs, the nill used to fit the
model is higher than the number of people ill at that time. At t > tfs, the die-off assumption
will not hold as the bacterial population will enter the growth phase in the human body,
which results in illness. Hence the time-independent dose-response relationship is given by
eq. 3.4.
P (d) = 1− (1− exp(−µtfs))d (3.4)
Here, d is the ingested dose of bacteria that, P (d) is the response probability, µ is the rate of
death, and tfs is the latest time at which the first symptom is observed among all subjects.
I refer to this model as the SD DRM through the remainder of this chapter unless specified
otherwise.
3.2.2 Relationship with the existing DRMs
The exponential DRM [57] is a widely used and best accepted model for dose-response of
pathogenic E. coli in humans. It is expressed as
P (d) = 1− exp(−rd) (3.5)
where r is the probability of the pathogen surviving to cause infection once it is ingested.
When comparing the SD DRM with the exponential DRM, it is clear that exponential DRM
is a special case of the time dependent SD DRM (eq. 3.3) where t = tfs.
(1− exp(−µtfs)) = exp(−r) (3.6)
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This result implies that SD DRM will fit any dataset that the exponential DRM fits. In
addition, the SD DRM establishes a link between an abstract parameter that is informed by
dose-response data (r) and a parameter that has a clear biophysical interpretation (µ). This
biophysical parameter becomes instrumental in accounting for the effect of the AB.
Similarly, the above approach can also be extended to the existing beta-Poisson DRM, if a
relationship between the beta-Poisson DRM parameters and the death rate (µ) of the SD
DRM is established. The beta-Poisson DRM is an approximation of the hypergeometric
DRM [57]. In other words, the hypergeometric DRM is a generalized case of the exponential
DRM, where the r value is assumed to be beta distributed. The classical beta-Poisson is
DRM given by:
P (d) = 1−
(
1 +
(d
β
))−α
(3.7)
where α and β are the parameters of beta-Poisson model. An analytical approach to finding
the required relationship was not tractable, and instead, I adopted a numerical approach
(see section 3.4). With this relationship, the beta-Poisson model can also be investigated
under AB loads. Thus, the results demonstrate that the SD approach provides a unified
framework to analyze the effect of ABs on dose-response.
3.2.3 Accounting for residual AB concentration
In addition to the dose of ARB (or the fr, the fraction of resistant bacteria in the dose),
the human health outcome also depends on C, the concentration of sub-lethal/residual AB
in human body. To account for the effect of AB, one can first adopt models that relate AB
concentration and E. coli death rate published in literature e.g. [100, 99, 20]). These death
rates can then be related to dose-response by using eq. 3.6.
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AB causes a significant increase in the death rate of ASB but has less or no effect on ARB.
Hence, a simple conservative assumption is that the ARB death rate is not affected by the
presence of AB. This assumption is the worst-case scenario because it does not include the
fitness cost of AB resistance [153]. I illustrate this relationship with a case study in which
I investigate the effect of Gentamicin on a dose of E. coli. The increased death rate of the
susceptible strain in the presence of AB (µs,AB) is given by the sigmoidal model of [99] as
µs,AB(C) = µ+
EmaxC
EC50 + C
(3.8)
C is the concentration of AB. µ is the death rate of the ASB strain in the absence of AB.
It can be obtained from eq. 3.6. Emax (= 1224 day−1, the maximum killing rate) and EC50
(= 9.93 mg L−1, AB concentration at half maximum killing rate) are values that determine
how C affects µs,AB(C). I obtained numerical values for Emax and EC50 from [99], where the
effect of Gentamicin on E. coli death kinetics was studied. The death rate of the ARB in the
presence of AB (µr,AB) is µ as per the earlier assumption. The probability of illness of doses
consisting of purely ASB or purely ARB can thus be estimated by plugging the estimated
µs,AB(C) into eq. 3.4.
3.2.4 Accounting for fraction of ARB
I account for fr by first assuming, like in existing DRMs, that any two bacteria act indepen-
dently of each other. Scaling this up implies that the susceptible and resistant subpopulations
will also act independent of each other. Therefore, the joint probabilities concerning both
subpopulations can be written as the product of the probabilities of each subpopulation.
For example, the probability of both subpopulations going extinct (SextRext in Table 3.2) is
given by Pext,s(d|fr, C) × Pext,r(d|fr, C). Therefore the probability of response (P (d|fr, C))
is equal to the complement of the probability of both populations going extinct i.e,
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Ssur Sext
(1− Pext,s(d|fr, C)) (Pext,s(d|fr, C))
Rsur (SsurRsur) Illness (SextRsur) Illness
(1− Pext,r(d|fr, C)) AB Treatable AB Untreatable
Rext (SsurRext) Illness (SextRext) No illness
(Pext,r(d|fr, C)) AB Treatable
Table 3.2: Possible outcomes (S: susceptible, R: resistant, sur: survives and ext: goes extinct)
P (d|fr, C) = 1− Pext,s(d|fr, C)Pext,r(d|fr, C) (3.9)
where the extinction probability of the susceptible subpopulation is
Pext,s(d|fr, C) = (1− exp(−µs,AB(C)tfs))d×(1−fr) (3.10)
and the extinction probability of the resistant subpopulation is
Pext,r(d|fr, C) = (1− exp(−µr,ABtfs))d×fr (3.11)
3.2.5 Possible health outcomes
Two types of health outcomes are possible when a mixed dose of ARB and ASB are involved.
When the ASB strain out-competes the ARB strain (SsurRext, Table 3.2) to grow and infect
the host, the illness would likely be susceptible to the AB treatment under consideration.
However, when the ARB subpopulation continues to survive irrespective of what happens
to the ASB subpopulation (SsurRsur and SextRsur), the resulting illness may not be treatable
with the AB. I label these health outcomes as ‘AB Treatable’ and ‘AB Untreatable’ illness,
respectively (Fig. 3.2). To identify the type of health outcome given an illness occurs, I
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compare the probabilities of these two events and classify as follows:

AB Treatable, (1− Pext,s(d, t|fr, C))Pext,r(d, t|fr, C) > (1− Pext,r(d, t|fr, C))
AB Untreatable, otherwise
Figure 3.2: Effect of varying fr and C on illness outcomes. (a) Exponential DRM, DS1,
fr = 0.05. (b) Exponential DRM, DS1, C = 1% MIC. (c) beta-Poisson DRM, DS2, fr =
0.05. (d) beta-Poisson DRM, DS2, C = 1% MIC.
Taken together, the risk of infection due to mixed doses (consisting of ARB and ASB) can
be estimated as a function of C. I predict the host response to AB treatment based on the
subpopulation of the AB resistant E. coli ingested. The implementation of this approach
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differs from the currently used exponential and beta-Poisson DRMs.
3.2.6 Effect of ARB fraction fr and residual AB concentration C
To understand the effect of ARB fraction fr and residual AB concentration C, the first step
is identifying the death rate of the ASB population (µ in eq. 3.8). To this end, I fit the
existing exponential and beta-Poisson DRMs to the human clinical datasets (see Table B.1,
data obtained from QMRA Wiki [142]) under consideration. Dataset 1 (DS1) uses mild to
severe diarrhea as the endpoint to measure positive response, while dataset 2 (DS2) uses
diarrhea. Both datasets use oral route of exposure to E. coli and exhibit a significant trend
at the 0.05 level (one-tailed Cochran-Armitage test [57], n = 6 and P value = 1.91×10−4 for
DS1, n = 11 and P value = 1.11×10−5 for DS2).
Fig. 3.3 presents the DRM fits and Table 3.3 summarizes the DRM choice for each dataset
based on the χ2 test, which is used for model selection for DRMs [57]. The results show that
the exponential DRM fits DS1 better, while the beta-Poisson DRM fits DS2 better. The
fitted parameters allow one to determine µ, which can then be used to estimate the death
rate in the presence of AB (µs,AB) using eq. 3.8.
Fig. 3.2 shows the model behavior at different values of fr and C. For a given dose of bacteria
and a given fr, increasing the concentration of AB decreases the risk (Fig. 3.2a, c). This is
expected as the higher AB load kills off more of the bacteria. When fr = 0.05, increasing C
from 0 to 2.5% MIC decreases the risk by around 1.5 orders of magnitude. This decrease in
risk is more gradual for DS1 (Fig. 3.2a) compared to DS2 (Fig. 3.2c). Not much difference
is observed between 1% MIC and 2.5% MIC for DS2, suggesting that the antibiotic effect
saturates at small fractions of the MIC. However, increasing C also increases the likelihood
of the illness not treatable by the AB (Fig. 3.2a, c, ‘AB Untreatable’). This is attributed
to the higher survival capability (or lower death rate) of the ARB subpopulation compared
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Data Case Dev χ2 p-value Conclusion Model
DS1 Exp 3.19 11.07 0.67 Fail to reject
“Exp is a good
fit".
Exp
beta-Poisson 0.95 9.49 0.92 Fail to reject
“beta-Poisson is
a good fit".
r = 1.07 ×
10−8
Compare 2.24* 3.84 0.13 Fail to re-
ject “Exp fits
better than
beta-Poisson".
(µ = 18.35
day−1)
DS2 Exp 57.82 18.31 9.36× 10−8 Reject “Exp is a
good fit".
beta-Poisson
beta-Poisson 14.44 16.92 0.11 Fail to reject
“beta-Poisson is
a good fit".
α = 0.16
Compare 43.38* 3.84 4.51× 10−11 Reject “Exp
fits better than
beta-Poisson".
β = 1.41×106
Table 3.3: Fit of the exponential and beta-Poisson DRMs. ‘Dev’ is the minimum deviance,
except the starred (*) values, which are the differences in minimum deviance between expo-
nential and beta-Poisson RMs. ‘Model’ represents the preferred DRM based on conclusions.
Best fit parameters are also shown.
to the ASB subpopulation. Further difference between DS1 and DS2 is observed, as the
concentration of Gentamicin that results in predominantly AB untreatable illness is > 1%
MIC for DS1 but < 1% for DS2.
For a given dose of bacteria and a given C, increasing fr also causes an increased risk and
greater likelihood of the AB untreatable illness (Fig. 3.2b, d). The higher risk is due to
the lower death rate of the ARB subpopulation. The greater likelihood of AB Untreatable
illness stems from the greater number of ARB in the initial load, meaning more ARB are
likely to survive with time. Specifically, changing fr appears to have little effect under DS1
when C is fixed to 1% MIC, indicating that antibiotic effect is near saturation. In contrast,
increasing fr from 0 to 0.1 under DS2 increases risk by two orders of magnitude, indicating
that antibiotic effect reaches saturation at > 1% MIC. The switch from AB Treatable occurs
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Figure 3.3: Model fits for (a) DS 1 and (b) DS 2. To avoid overlapping points in the plot,
noise is added along the horizontal axis.
at 0.05 < fr < 0.1 under DS1 but at fr < 0.01 under DS2.
The magnitude of the impact of fr and C depends on the DRM and the datasets used to
fit the DRM (Fig. 3.2). To better understand this dependence, I performed a sensitivity
analysis using the PAWN algorithm [105] (see section 3.4). The results show that the dose of
bacteria is the biggest determinant of risk for both the exponential and beta-Poisson DRMs
(Fig. 3.4a, b). When one fixes the dose of bacteria, C and fr play a bigger role in determining
risk than the dose-response parameters (Fig. 3.4c, d). The parameters capturing the effect
of the AB (Emax and EC50) play a smaller role than the dose-response parameters (Fig. 3.4c,
d). Further, I verified that setting t = tfs has a minimal effect on the final results since
sensitivity indices of tfs fall below the threshold value, indicating that tfs is non-influential
(Fig. 3.4).
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Figure 3.4: PAWN sensitivity index distributions, higher values are more influential param-
eters. The dashed line is the threshold value at level of significance = 0.05 (see section 3.4).
(a) Exponential DRM, along with dose of bacteria (d). (b) beta-Poisson DRM, along with
d.(c) Exponential DRM, fixed d.(d) beta-Poisson DRM, fixed d.
3.3 Discussion
While AB resistance is recognized as a growing problem, few studies have attempted devel-
oping a quantitative understanding of the risk posed by ARB and the associated sub-lethal
AB concentration. I propose a new approach to modeling the dose-response of ARB under
the Quantitative Microbial Risk Assessment (QMRA) framework. Under this framework,
once a pathogen is identified, human exposure to it is quantified. Exposure is coupled with
DRMs to estimate the risk of positive response, which is used to design risk management
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measures.
The crux of the proposed approach is the stochastic process known as the SD process. I
model the kinetics of the bacterial dose under the SD assumption, resulting in an analytical
expression for the extinction probability (Pext). Like in existing DRMs, response probability
is defined as 1 - Pext. The resulting expression establishes a link between the death rate, which
is an experimentally observable parameter, and dose-response parameters (eq. 3.6). Since
the relationship between AB concentration and death rates is known (eq. 3.8), we are also
able to relate AB load to dose-response. Further, treating the ASB and ARB subpopulations
independently, we can compute the odds of the successful treatment with AB in the infected
subpopulation.
A significant advantage of the proposed approach is that it meshes well with the existing
DRMs. An additional choice of DRM, which could complicate the decision of a practitioner, is
not necessary. Moreover, the proposed approach does not change the workflow of traditional
QMRAs. Instead, it provides additional capabilities relevant to antibiotic resistance. It can
be used to predict the dose-response of ARB if one has information on 1) the dose-response
of ASB, and 2) kinetics of ARB and how it relates to ASB (discussed below).
Additionally, if one suspects exposure to antibiotics in the risk assessment, its influence
on human health outcomes can be accounted for using eq. 3.8. Since I introduce a novel
approach to DRMs, I provide an outline of the steps, along with an example (see section B.4).
As shown, the approach works equally well with exponential and beta-Poisson models to
compute dose-response for a single exposure. The total risk from multiple exposures can be
calculated in the usual way by assuming independence between exposures [57]. For example,
the annual risk can be computed from daily risk estimates by assuming that one day’s risk
does not affect another day’s risk.
The conservative assumption enabling this approach is that the ARB and ASB subpopu-
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lation have the same death rate in the absence of AB. If there is evidence for significant
differences in death rates in the absence of AB (due to the absence of mutations to compen-
sate fitness loss), then this difference can be set to µ′ − µ. Here µ′ is the ‘base’ death rate
for the ARB, which will be higher than the death rate of ASB (µ). Then µr,AB = µ′ + f(C)
, where f(C) is the concentration-dependent effect of the AB on the death rate. Another
assumption made is that there are only two kinds of bacteria, ARB and ASB. However,
resistance may vary in degree in different subpopulations. If one suspects multiple subpopu-
lations (e.g., with different Emax values), one can assume their independence and adopt the
probabilistic framework easily. In fact, the framework presented here can also be used for
samples containing a mixture of different pathogens present in an environmental sample to
estimate the total risk due to all the pathogens.
As a proof of concept, I investigated the case study of E. coli and the AB Gentamicin. I
found that the AB concentration C and the fraction of ARB fr emerged as influential pa-
rameters affecting the health outcome from a global sensitivity analysis. A rigorous exposure
assessment to quantify C and fr would thus be necessary to get accurate results in a QMRA.
The AB-bacteria interaction parameters (Emax, EC50) seem less influential for Gentamicin.
This supports the use of these parameters, that were determined in-vitro [99], in a host sys-
tem. A similar analysis would need to be carried out for different AB-bacteria combinations
to draw generalized conclusions.
A critique of this approach is that it fails to account for the details in the biological system.
For example, the precise concentration of AB in the vicinity of the bacteria is difficult to
estimate and likely varies in time. The bacteria themselves translocate from the point of entry
to the site of infection (e.g., travel through the alimentary canal). A more detailed stochastic
model for dose-response (with compartments or spatial distributions) may better reflect the
underlying system but would be significantly harder to parameterize adequately. Analytical
expressions will also be harder to come by, and the approach may require dynamic simulations
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for dose-response. Hence, I believe that the proposed approach provides a framework as a
first step to solve the problem. For example, the range of variation in the outcome due to
the change in C with time can be captured by investigating the outcomes at several fixed
concentrations.
When assuming that the probability of observing a response (illness) equals the probability
of not observing an extinction (eq. 3.1), I am not accounting for the carrier population.
These are the individuals who harbor the pathogen but do not show any visible symptoms
(infected but not ill). One could gain insight into the probability of infection in addition to
the probability of illness if the dataset had information on the number infected. The proposed
approach can be used to compute the probability of observing the response (infection). The
probability of illness can then be computed by multiplying this quantity by the constant
probability of illness given infection (as is done for norovirus in [89]). However, if evidence
suggests that ARB are more virulent than the ASB, this approach will underestimate the
illness risk. Here I distinguish between virulence (observed in-vivo) and fitness or growth
rate, which can be observed in-vitro. The latter can be accounted for using the death rates,
as discussed above. In summary, although the approach discussed here does not explicitly
deal with illness and infection, the framework presented can be applied to this end if the
data are available.
HGT and spontaneous mutation can result in the creation of ARB, which can potentially
influence the type of health outcome. The SD DRM presented here can be modified to
investigate the importance of these processes. For example, conjugation is modeled as a
second-order reaction (first order in ASB population (d(1 − fr)) and first-order in ARB
population (dfr)) [86]. A conservative estimate of rate constant of conjugation for E. coli
is rconj = 2.4× 10−11mL cells−1day−1 [86]. Hence the observed rate of conjugation becomes
comparable to observed net death rates ( µ = 18.35 day−1 for DS1, Table 3.3) only if either
the ARB or ASB subpopulation number around 1010cells mL−1. This is extremely high
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and atypical of what is expected from environmental exposure, suggesting that conjugation
does not affect dose-response significantly. Judging the importance of transduction and
transformation is non-trivial as the numbers of phages and MGEs must be accounted for,
respectively. Nevertheless, if these quantities were known along with the associated rates,
the SD framework can be modified to account for them.
The SD framework can be applied to both the exponential and the beta-Poisson DRMs.
Hence, this framework can be used to understand the effect of antibiotics on other bacteria
for which these models are applicable. However, for a given organism, the best DRM relies
on the objective of the QMRA being pursued and the dataset chosen [142]. In this study,
the two different datasets for E. coli yield two different best fit models. Risk predictions also
depend to a large extent on the dataset chosen. Deciding on the ‘best’ dataset or DRM for
E. coli is beyond the scope of this chapter and is dicussed in the QMRA Wiki website [142].
Nevertheless, the SD framework accommodates both DRMs and provides the capability to
investigate antibiotic resistance.
One limitation of applying this approach is the paucity of experimental data at each step.
While in-vitro experiments [99] are used to capture the effect of the concentration of AB
on bacteria, most studies on AB-bacteria interactions do not model the concentration-rate
relationship, and instead report summary metrics of therapeutic importance [100]. While I
have worked only with human datasets in this study, animal experiments may provide better
quality data. Nevertheless, whether quantitative conclusions can transfer from animals to
humans is debatable, as even human datasets (such as DS1 and DS2) show variability.
Another area with insufficient data is the enumeration of ARB. Several studies reporting
ARB occurrence in the environment report binary results (presence/absence) for each sample.
Others report occurrence summaries such as ‘23% samples tested positive for ARB’ (e.g.,
[87]). Only a few studies (e.g., [46, 56]) report the fraction of resistant bacteria in a single
sample. Additional data collection at these stages will enable risk assessment case studies.
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3.4 Methods
3.4.1 Fitting the model to data
I fitted the model to two E.coli datasets which are listed in Table B.1 along with the corre-
sponding tfs. I placed a binomial likelihood on the data as follows:
nill ∼ Binomial(ntot, P (d, tfs)) (3.12)
This approach is commonly used in building DRMs and amounts to minimizing the deviance
presented in [57]. I used the differential evolution algorithm [126] from DEoptim package [98]
in the R[110] programming language to fit the data. The effect of varying ARB fr at constant
AB concentration C = 1%MIC (minimum inhibitory concentration = 2 µg/mL) and varying
C at constant fr = 0.05 are presented in Fig. 3.2. (The effect of antibiotic concentration C
is incorporated in the model by increasing the death rate according to eq. 3.8).
The analytical approach described above suffices to fit the exponential DRM. However,
this DRM fails to provide a satisfactory fit for some datasets, for which the beta-Poisson
DRM provides a better fit and is often used as an alternative. As seen in the case for DS2
(Table 3.3), the beta-Poisson DRM fits the data better. However, this model does not have
a ready r value that can be related to the death rate. A numerical simulation is necessary
to parameterize the model to include the individual death rate.
The beta-Poisson DRM assumes that the survival probability of the pathogen, r, follows a
Beta distribution (with parameters α and β). This is different from the exponential DRM,
where r is assumed to be the same for all pathogens. The exact probability of illness can be
challenging to compute, and I used the relationship in eq. 3.7. To relate α and β to the death
rate of the susceptible strain in the presence of AB (µs,AB), I used the following approach:
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1. Generate N random values of r (r1, r2, ...rN) from a Beta distribution with parameters
α and β.
2. Compute the corresponding µi values using eq. 3.6 for each ri.
3. For known values of C, Emax, EC50, and µi, compute µs,AB,i using eq. 3.8.
4. Compute the corresponding rs,i from µs,AB,i using eq. 3.6.
5. Fit a Beta distribution to theN samples of rs,i and obtain the distribution’s parameters,
αs and βs. These can then be plugged into eq. 3.7 to estimate P (d).
The approach outlined above is straightforward, but in practice, numerical issues are encoun-
tered due to the extremely small (≤ 1× 10−16) values of r. Hence I used the fitdistrplus
package [36] in R. I verified that this procedure produces satisfactory estimates (see Fig. B.1).
3.4.2 Sensitivity Analysis
A global sensitivity analysis was carried out using the PAWN algorithm[105] (algorithm name
formed from author names), which measures sensitivity from the entire probability density
of the output rather than just the variance of the output. Sensitivity is not characterized by
a point estimate, but a list of estimates (PAWN indices) to give a fuller picture, with higher
magnitudes representing more influential parameters. The algorithm parameters are n = 15,
Nu = Nc = 100. Both the exponential and beta-Poisson DRMs were considered separately.
The analysis was re-run after fixing the dose of bacteria to understand the effect of the
remaining parameters (Fig. 3.4). A threshold value was calculated at the 0.05 significance
level to identify non-influential parameters (dashed line, Fig. 3.4). Parameters with PAWN
indices entirely below the threshold line are non-influential parameters. The parameter
ranges in which sensitivity was investigated are described in Table B.2 and Table B.3.
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3.4.3 Data availability
Codes reproducing the results in this chapter are available on Github at https://github.
com/JiangLabUCI/AbResistantDoseResponse.
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Chapter 4
Role of quorum sensing in microbial
pathogensis
4.1 Background
Pathogens in the environment present a growing threat to human health. Understanding
and quantifying the health risk that they pose is critical to make decisions on risk manage-
ment. To this end, it is essential to quantify the relationship between the level of pathogens
a person is exposed to (dose) and the associated probability of an adverse event (response),
which is achieved by dose-response models (DRMs). A cornerstone of dose-response is the
independent action hypothesis, which assumes that the pathogens in the microbial exposure
load do not interact with one another to initiate infection. Making assumptions on distribu-
tions of the number of pathogens ingested from the exposure and the number of pathogens
that survive to cause disease leads to several different DRMs. Of these, the most common
are the exponential and beta-Poisson DRMs [57].
A fundamental assumption of the exponential and beta-Poisson models is the single-hit
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hypothesis [94, 57], which postulates that only one organism needs to survive to initiate
infection. Meynell and Stocker [94] draw an analogy to bullets fired at a target bottle, of
which only one hits the bottle and breaks it. In contrast, the multi-hit hypothesis relaxes
this criterion by assuming that at least kmin(> 1) organisms need to survive to initiate
infection [57]. In terms of the bullet-bottle analogy, each bullet hits the bottle, but its
cumulative effect of bullets that finally breaks the bottle. The multi-hit hypothesis has thus
been interpreted as one of cooperation between the organisms in achieving infection, as one
organism is incapable of initiating infection [57]. Nevertheless, the single-hit hypothesis is
more widely accepted [117], and the corresponding DRMs are more frequently used [57].
The phrase ‘multi-hit’ has been used interchangeably with ‘cooperative’ in the literature,
even though classical multi-hit models stem from the independent action hypothesis [57]. I
resolve this seemingly counterintuitive relationship between cooperativity and independent
action by introducing the term ‘cooperativity in effect’. I use this term to describe the
situations resembling the bullet analogy: when the actions of agents are independent, but
the effect of their actions is cumulative. A fired bullet does not interact with any other fired
bullet, but the accumulated stress of their impacts breaks the bottle.
In contrast, I also introduce the term ‘cooperativity in action’, which I define as: when the
actions of agents are non-independent. This cooperativity is analogous to soccer (or other
team sports), where one individual may score a goal, but it would not have been possible
without help from the teammates. In the context of infectious diseases, cooperativity in
action occurs when there is quorum sensing, i.e., when signals from one microbe influence
the actions of another microbe. The role of quorum sensing in pathogenesis and establishing
disease has been observed for several bacteria e.g., Pseudomonas aeruginosa [81], Staphylo-
coccus aureus [77] and Streptococcus [31] (see [34] for other pathogens). Taking the soccer
analogy further, winning a match may be attributed to the goals scored by one or more
players.
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Similarly, infection may develop due to the survival (and subsequent replication) of one or
more clones. Classical dose-response does not account for cooperativity in action as the
associated models assume the independent action hypothesis. In this work, I introduce a
two-compartmental (2C) model of bacterial kinetics for dose-response. A single parameter
represents cooperativity in action, and I parameterize the model for the pathogenesis of S.
aureus on human skin.
Classical dose-response does not address another aspect, the carrier population. These are
the individuals who do not show symptoms when colonized, who form a not insignificant
proportion of the population in the case of S. aureus [19]. Sometimes, this population is
estimated when the response data on colonization is available. I show that the response data
on symptoms may suffice to predict the carrier population by assuming that response occurs
when pathogen load exceeds a threshold (called individual effective dose, [70]). Additionally,
being a kinetics based DRM, the 2C model can be used to probe 1) non-instantaneous
exposures [109] 2) environment-host transmission dynamics with multiple exposures, without
assuming independence between exposures 3) effect of antibiotics and antibiotic-resistant
strains [26].
4.2 Results
4.2.1 Deterministic model of kinetics
Studies have observed that pathogens transferred to a host sometimes undergo an initial
decay before growing in numbers to cause infection [44, 40, 123]. We hypothesize that this is
due to the existence of two distinct states of the pathogen, S1 and S2 (Fig. 4.1A). Bacteria
deposited in a new hostile environment (such as the host) are in S1. They can transition
to the state S2, which is well adjusted to the environment and exhibits density-dependent
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Figure 4.1: A) 2C model schematic B) Phase plot of 2C model C) Logistic process schematic
D) Variations in 2C stochastic simulation (each region bounds mean ± SD of 50 simulations)
E) Human health outcome classification according to SA dynamics
growth. Suppose h(t) and i(t) represent the density of pathogens in S1 and S2 respectively.
The differential equation representing S1-S2 dynamics is given by:
dh(t)
dt
= −r1h(t)− r2h(t) (4.1)
di(t)
dt
= r2h(t) + r3i(t)(imax − i(t)) (4.2)
Here, r1 is the rate of death of cells in S1. r2 is the S1-S2 transition rate. r3 is the logistic
growth rate of cells in S2, and imax is the logistic carrying capacity. I call this model the two-
compartment or 2C model (Fig. 4.1A). The model has two critical points at [0, 0] and [0, imax]
(Fig. 4.1B). The former is unstable, whereas the latter is asymptotically stable. In other
words, if the system is nudged away from the unstable critical point at [0, 0] (by addition
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of bacteria to the system), it will move towards the other critical point at [0, imax]. Note
that this system represents the density of pathogens and not their numbers, as differential
equations are not restricted to integer values.
4.2.2 Stochastic model of dose-response
The stochastic version of the 2C model is captured with continuous time Markov chains [3],
which restrict bacterial numbers to integer values. The first order reactions associated with
r1 and r2 (eq. 4.1) are easily represented in this framework by a simple death processes with
death rates r1 and r2 respectively. The r2 term in eq. 4.2 is represented by a simple birth
process with birth rate r2.
Interestingly, the logistic growth component in eq. 4.2 is more involved and the logistic growth
process [3] is used. In essence, the logistic growth process is equivalent to the deterministic
logistic equation. It is used when the system has a small number of entities being tracked.
It consists of two first and two second-order processes, given by the elementary reactions
defined in (Fig. 4.1C). The relationships between the rates of these processes (d1, b1, d2 and
b2) and the deterministic constants (r3 and imax) are given by [3]
b1 − d1 = r3imax (4.3)
b2 − d2 = 2(−r3)/A (4.4)
Here, I note that the factor 2/A stems from the size of the system (2D system with surface
area = A), which needs to be accounted for in second-order systems [50]. The first order
components (associated with d1 and b1) are density-independent and reflect the death and
division of cells independent of other cells. The second-order components (associated with
d1 and b2) are density-dependent and reflect the growth and death of cells as influenced by
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the number of cells in their neighborhood. d2 is the effect of competition of resources used
by the cells, creating an upper limit on the population size. I interpret b2 as the effect of
quorum sensing, where signals from the other cells enhance the division rate of a given cell.
This effect grows stronger with increasing cell numbers.
To understand the effect of these first and second-order processes on dynamics, I consider the
case where the deterministic rates (r3 and imax) are known. Eq. 4.3 constrains the first and
second-order processes, reducing the degrees of freedom to two. Picking values for d1 > 0
and b2 > 0 thus fully determines the behavior of the system (Fig. 4.1B). Setting b2 = d1 = 0
results in a small variance around the mean, where the mean is determined by the solving
the deterministic system (see Fig. 4.1D). Setting b1 to a nonzero value while holding b2 = 0
increases the variance. Interestingly, giving b2 a nonzero value and holding d1 = 0 increases
the variance dramatically. This increases the odds of the pathogen population going to 0
and causing no symptoms. Therefore, b2 serves as a knob that controls variance to influence
pathogenesis and dose-response outcomes.
I evaluated dose-response outcomes using the concept of individual effective dose or IED
[70]. Individuals with a total bacterial load (in states S1 + S2) above IED (represented by
ithresh), as done in other studies using CTMCs representing kinetics-based DRMs [147, 109]
(see Fig. 4.1E). Individuals in whom bacteria die out completely represent the unaffected.
Individuals who fit neither category, in whom the bacterial load takes an intermediate value,
represent the carrier population. We have assumed bacteria in the un-adapted S1 state
contribute to the threshold, which will not matter much if r1 > r2 as most of the bacteria in
the S1 state will die out before bacteria in S2 establish infection.
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Inoculation density (CFU/cm2) nˆres ntot Pˆres
40 4 20 0.20
220 8 20 0.40
2000 13 20 0.65
105000 14 20 0.70
1600000 19 20 0.95
10000000 20 20 1.00
Table 4.1: Dose-response data from [123]. nˆres and ntot as defined in the text
4.2.3 Parameterizing the model
I parameterized the model with data from the Singh et al. study [123]. They performed a
clinical trial in which the participants’ hands were cleaned with alcohol before inoculation
with a known dose of SA. The area was covered immediately with a patch of polyethylene
film to distribute the inoculum underneath it uniformly. Bacterial densities in the covered
area was measured over six days (growth data). This was used to identify the parameters
r1, r2, r3 and imax by a procedure outlined in the Methods.
Singh et al. also counted the number of people who developed lesions by day 6 for a given
dose (dose-response data, Table 4.1). This data was used to identify the rate parameters (b2
or d1) and IED (ithresh). For this, the response probability (Pres) was estimated by counting
the fraction of stochastic simulations in which (h(t)+i(t))A ≥ ithresh. This predicted response
probability was used to minimize the deviance given by
∑
j
−2
(
nˆres,j log
(
Pres,j
Pˆres,j
)
+ (ntot,j − nˆres,j) log
(
1− Pres,j
1− Pˆres,j
))
(4.5)
and identify the unknown parameters. The dose-response data was verified to exhibit a trend
according to the Cochran-Armitage test with ZCA = 6.29, P=1.55×10−10 [57]. The fitting
procedure is outlined in the methods.
Some points of note are: 1) I compute the probabilities of unaffected and carrier outcomes by
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Model Min. dev. χ2degrees,0.05 P Conclusion
2C(d1 = 0) 6.34 χ24,0.05 = 9.49 0.18 Fail to reject
2C(b2 = 0) 16.24 χ24,0.05 = 9.49 2.71×10−3 Reject
Beta-Poisson 6.40 χ24,0.05 = 9.49 0.17 Fail to reject
RH model 5.50 χ24,0.05 = 11.07 0.36 Fail to reject
Table 4.2: Summary of model fits. Min. dev. is the minimum deviance from best fit
obtained.
their corresponding fractions of simulations i.e, simulations with zero load and simulations
with intermediate load (0 < (h(t) + i(t))A < ithresh). 2) the b and d values discussed in this
study correspond to stochastic rate constants (cµ in [50]) and not the standard (determinis-
tic) rate constants. Stochastic rate constants are used for simulating numbers (CFU) with
continuous-time Markov chains, whereas standard rate constants are used for simulating
densities or concentrations (CFU/cm2) with differential equations. 3) imax, the carrying ca-
pacity, is interpreted as the mean of the SA densities observed in a population of individuals
in whom SA is not wiped out. It differs from the IED (ithresh), which is interpreted as the
SA load above which an individual from the population will show response.
4.2.4 Assessing the fit
I compared the quality of the dose-response fit with two baselines: 1) the beta-Poisson
model and 2) the quasi-mechanistic DRM of Rose and Haas (RH model) [116] with results
presented in Table 4.2. The 2C model, with d1 = 0 fits the data as well as the beta-Poisson
and RH models at the 0.05 significance level. Setting b2 = 0 fails to fit the data at the 0.05
significance level, and so I rejected this hypothesis.
Biologically speaking, these results mean the following: 1) Under the umbrella of the 2C
model and its assumptions (existence of 2 states S1 and S2, response predicted by IED),
cooperativity in action is necessary to explain SA dose-response 2) cooperativity in action
is an alternate hypothesis to independent action + constant infectivity (RH model) and
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independent action + variable infectivity (beta-Poisson model). However, neither the RH
model nor beta-Poisson model can explain the carrier population without additional data.
Therefore, I favor the 2C model with cooperativity in action (b2 = 0, d1 6= 0) and restrict
further discussion to its properties and capabilities.
The optimization algorithm used to fit the deterministic model (see Methods) provided a
single best-fit parameter set and additional less-optimal parameter sets of varying quality.
Using values (r1, r2, r3 and imax) from such sub-optimal solutions to fit eq. 4.5 improved the
fit to the dose-response objective function (eq. 4.5). An explanation for this observation is
that the best-fit to growth data overfits that data. This two-step optimization procedure
sheds light on parameter uncertainties and the trade-off between fitting the growth and dose-
response data. The trade-off and the rank one solutions (solutions with no other solution
better than them) are presented in Fig. 4.2A and Table C.1 respectively.
I chose two rank 1 solutions to illustrate the fit of the 2C model (colored in Fig. 4.2A). The
deterministic model is compared with the model of [116] (labeled RH model) in Fig. 4.2B.
The 2C model fits the data better than the RH model, as seen by the sum of squared errors
(SSE). The 2C model also predicts a more gradual decay compared to the RH model.
A visual comparison of the fit of the stochastic 2C model with other models is presented
in Fig. 4.2C. The better performance of RH and BP models compared to the 2C model is
visually less discernible. Compared with Fig. 4.2B, the solution with a lower SSE has a
higher deviance, indicating the trade-off between fitting growth and dose-response data.
Fig. 4.2D shows the probabilities of unaffected, response, and carrier outcomes across a range
of bacterial doses. The height of each color for a given dose is the probability of the outcome
associated with that color. The probability of the response outcome increases with increasing
dose, as expected. Carrier probability increases and then decreases with increasing dose.
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Figure 4.2: 2C model fit and predictions. (A) Plot of the dose-response objective function
value (deviance) vs. the growth objective (SSE). Pareto rank 1 solutions (with no solution
better than them) are connected by the Pareto front. Solutions at the extremes of the pareto
front are colored. (B) Best fits of the 2C and RH models to growth data. (C) Best fits of
the 2C and RH models to dose-response data. (D) Plot of the outcome probabilities as a
function of the dose. For a given dose, the height of a colored region is the probability of
the corresponding outcome, with the sum of the heights of each region totalling 1.
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4.2.5 Parameters in absence of alcohol pre-treatment
As mentioned earlier, [123] treated their subjects with alcohol before administering SA,
effectively reducing the resident microflora load on the skin. In comparison, [116] report
an experiment similar to [123] wherein the subjects were inoculated with SA 24 hours after
using regular soap. We assume the skin resident microflora exerts a competitive pressure
that acts as a constant first-order death rate on SA. To determine the fit of the 2C model
to this more realistic scenario, I explore the model fit under the following two hypotheses:
The first hypothesis (which I call r1∗) assumes that only the un-adapted SA are affected by
the resident microflora. The model (eq. 4.1 & eq. 4.2) is modified to
dh(t)
dt
= −r∗1h(t)− r2h(t) (4.6)
di(t)
dt
= r2h(t) + r3i(t)(imax − i(t)) (4.7)
Here r∗1 reflects the increased r1, accounting for death by resident microflora. The second
hypothesis (which I call rmf) assumes that both un-adapted and adapted SA are affected by
resident microflora. The model (eq. 4.1 & eq. 4.2) is modified to
dh(t)
dt
= −r1h(t)− r2h(t)− rmfh(t) (4.8)
di(t)
dt
= r2h(t) + r3i(t)(imax − i(t))− rmfi(t) (4.9)
Other hypotheses may also fit the data from [116]. However, I only consider the hypotheses
that can be modeled with one additional parameter. This is because there are only four
data points, including the initial condition. Using two parameters to fit the three remain-
ing data points will result in over-fitting. For example, the corrected Akaike Information
Criterion (AICc, which corrects for small sample sizes) [69], for such a case (3 data points,
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Figure 4.3: 2C model in the absence of alcohol pre-treatment. Two different hypotheses
(r∗1 and rmf, described in text) were investigated. (A) Fit of the RH model and the two
hypotheses of the 2C model to data obtained in the absence of alcohol pre-treatment. (B
and C) Outcome probabilities for r∗1 and rmf hypothesis respectively.
2 parameters) will be infinity. The limited data also hindered testing of absolute goodness
of fit. Other hypotheses that can be captured by a single parameter change (e.g., resident
microbiota affecting r2) did not yield good fits (data not presented).
The fit of these two hypotheses, along with the approach of [116] are compared in Fig. 4.3A.
The RH model fits the data better because of the additional parameter. The r∗1 hypothesis
shows a sharper decline than the rmf hypothesis, but the available data does not strongly
support either hypothesis in favor of the other as indicated by their similar SSE values.
The difference between the hypotheses is striking when looking at their outcome probabilities
with increasing dose. The r∗1 hypothesis predicts a significant Pres at higher doses (Fig. 4.3B)
whereas the rmf hypothesis predicts almost zero Pres and carrier probability (Fig. 4.3C). This
is because the adapted SA also dies out from the inhibitory effect of the resident microflora.
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4.2.6 Parameters for MRSA
To see if the parameters found for MSSA could be used for MRSA, I looked at studies in
which both MSSA and MRSA were grown separately under similar conditions. Since the
growth curves for MSSA and MRSA were highly correlated across studies (see Table C.2), I
decided to use the MSSA parameters for MRSA.
4.2.7 Case study
To demonstrate the applicability of the model, I use it to predict the outcome probabilities
for patients in a hospital. As an example, I look at the bedside rails in a hospital as
an environmental reservoir of MRSA and the subsequent risk to a patient using that bed.
The patient’s exposure to MRSA is calculated as the product of the MRSA density/cm2
on bed-rails [78], area of hands [1], and the transfer efficiency from bed-rails to hands [2]
(see section 4.4). Exposure is assumed to randomly occur at a hand-bedside rail contact
frequency of 0.28 contacts/hour [27]. The environmental reservoir is assumed not to be
affected by contact events, which is possible if the patient touches different parts of the
bedside rails. In this way, I modeled the MRSA load in a patient staying in a hospital with
stochastics. I repeated this 1000 times to understand the probabilities of different outcomes.
Sample trajectories of the MRSA load on the patient over time are presented in Fig. 4.4A
(r∗1 hypothesis) and Fig. 4.4B (rmf hypothesis). The sudden increases in MRSA loads are
indicative of the random contact events. After this increase, the MRSA load encounters a
period of decay. In some cases, when the populations cross 104 CFU, the contact events are
not discernible from the general randomness in the simulation. Some trajectories under the
r∗1 hypothesis undergo an explosion while none of those under rmf do. The sharp increase at
the ends of the explosive trajectories (Fig. 4.4A, red lines) highlights the numerical difficulties
in simulating stochastic systems with a large number of entities.
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Figure 4.4: Case study (described in text) outcomes for the r∗1 and rmf hypotheses. (A
and B) Sample population trajectories of the case study for the two hypothesis. log10 (SA
population + 1) is plotted to avoid (negative) infinities. (C and D) Outcome probabilities
of the case study for the two hypotheses. Colors are as indicated in (A).
The distribution of outcome probabilities is given in Fig. 4.4C (r∗1) and Fig. 4.4D (rmf).
Initially, both hypotheses predict similar outcomes. At the end of day 1, they start to diverge
with r∗1 predicting an increasing likelihood of carrier outcomes and even predicting response
outcomes by day 6. On the other hand, rmf predicts a more or less constant probability
of carrier status and no response outcomes through day 6 (Fig. 4.4D). The corresponding
trajectories (Fig. 4.4B) explain this behavior, as MRSA loads from exposure events are not
large enough to overcome the decay and establish response. This is consistent with the trend
seen earlier (Fig. 4.2) of rmf predicting less adverse outcomes than r∗1.
4.3 Discussion
A two compartment model for SA dynamics on the human skin was developed and fitted
to data. By assuming that SA transitions from an un-adapted state to an adapted state,
the model is grounded in first principles. The stochastic aspect of dose-response emerges
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naturally from a stochastic simulation of the growth kinetics. In addition, the model predicts
carrier outcomes without additional data.
Armitage et al. [7] interpret results from several studies to posit that pathogens, including
bacteria, show an initial exponential increase in all individuals. We argue that this is not
inconsistent with the initial decrease assumption for three reasons. Firstly, the exponential
increase is observed in organs like the liver or spleen, and not the whole body or site of
inoculation (e.g., [66, 53]). This does not refute the possibility of an initial decrease at the
inoculation site or the whole body. Secondly, the posited decrease is transient, and samples
may not have been collected during this window. Thirdly, the magnitude of decrease is low
at higher inocula (e.g., Fig. 4.1B) and consequently less detectable. Further, compared to
the initial decrease observed when all bacteria are in the S1 state, one would expect 1) no
initial decrease if seeding with bacteria all in the S2 state, and 2) a smaller initial decrease if
seeding with a mixture of bacteria in the S1 and S2 state. These trends have been observed
when pathogens from in-vivo cultures were used for infecting the host [44, 151]. We note
that the transition from S1 to S2 is perhaps not instantaneous, and the pathogen population
may constitute a continuum of states between S1-S2.
When loads were measured in the whole body, a transient decrease was observed in some
cases (see Fig. 6 in Yamamura et al. [151]). Clumping of bacteria was offered as a possible
explanation [151], but this does not rule out an actual reduction in viable counts observed
in other systems (see [44, 123], Table 2 in [38]).
Armitage et al. [7] also note that non-responders show a subsequent decrease after the initial
exponential increase. These were substantiated by measurements from survivors who were
killed at later time points [63, 38]. This decrease is probably due to the activation of the
adaptive immune response inside the host, which could be incorporated in a within-host
variant of the 2C model.
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Using the concept of IED to evluate reponse, I am able to explain the data with a single
IED. It has been observed that the toxic dose of a chemical can vary between individual
subjects or with the season [133]. A similar stochasticity may be expected in IED between
individuals which can be attributed to differences in covariates such as body weight, sex,
immune history and biological noise. However, assuming this was not necessary to produce
an acceptable fit.
The model was fit to data by following a two step optimization procedure. Direct multi-
objective optimization was not pursued since the objective functions were very different from
each other. The deterministic ODE model was easy to evaluate and a global optimization
algorithm was employed to guard against local minima while fitting the growth data. Fit-
ting the dose-response data was computationally challenging for 3 reasons: a non-smooth
objective function, stochastic simulations have to be repeated many times, and the number
of stochastic entities being modeled is not small. Hence, a simple brute-force optimization
was adopted.
The RH model exhibits a sharp initial decline in SA density and predicts values lower than
the observed minimum for each initial load (Fig. 4.2B). The 2C model only goes as low as
the lowest load observed on the skin. Experiments similar to that of [116] with greater time
resolution are necessary to ascertain the time of true minimal SA density. The 2C model
stochastic model does not perform as well as the RH model (Fig. 4.2C). However, the 2C
model fit to dose-response data improves along the Pareto front (Fig. 4.2A). It is possible
that exploring solutions with a higher growth objective may yield a solution that fits as
well as, if not better than, the RH fit to the dose-response data. Moreover, the proposed
approach offers advantages over the existing approach in that 1) it is fully mechanistic, and
hence is more applicable in other scenarios (e.g. using MSSA parameters for MRSA, non-
instantaneous exposure, multiple exposure which is discussed here), and 2) in addition to
response outcomes, the proposed approach also accounts for carrier outcomes.
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Perhaps the most interesting outcome of this study is the incorporation of quorum sensing in
dose-response modeling. The rejection of the absence of cooperativity in SA pathogenesis and
the adequate fit of cooperativity make a strong case for the cooperativity in action hypothesis.
Experimental support for this hypothesis include the well studied Agr system of quorum
sensing [77, 80]. In the words of Le. et al, the Agr system “generally enhances pathogenesis
by increasing expression of aggressive virulence determinants such as toxins and degradative
enzymes" [80]. This system is activated when bacteria reach a certain density, which results in
a disease response such as a murine abscess [149]. However, the 2C model posits that quorum
sensing enhances bacterial growth rate, for which I propose two possible explanations. The
direct explanation is the existence of an as yet undiscovered signaling mechanism responsible
for density dependent growth enhancement. A second explanation relates to the events
initiating response in a host, which is the interaction of the toxins/enzymes produced by SA
with the host tissue. The 2C model captures these dynamics at a higher level of abstraction,
with the mathematical variable i(t) (or the S2 state) representing the amount QS signals
and toxins. We can interpret b2 as the rate of enhanced production of these factors. The 2C
model does not capture other observed dynamics, such as the down regulation of the Agr
system and its role in biofilm formation [80, 77].
The model was extended to more realistic situations where the SA inoculation area was not
alcohol treated by means of two competing hypotheses, r∗1 and rmf. These hypotheses predict
very different carrier and response probabilities. This is because the former assumes that the
adapted state is unaffected by resident microflora while the latter assumes that the adapted
and un-adapted states are equally affected. The truth is likely in the middle, i.e., SA in
the adapted state are affected by resident microflora to a lesser extent than SA in the un-
adapted state. Such an approach was not pursued in the spirit of avoiding over-fitting given
the limited data. We note that more data collected within the first day of inoculation will
help judge the quality of the hypotheses presented in this study, which need to be evaluated
on an absolute scale with a goodness of fit test. Confidence in the predictions of the model
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will improve as more data is gathered, either supporting or refuting the hypotheses.
The model’s applicability was demonstrated with a simple case study. The mechanistic
nature of the model enabled direct simulation of repeated exposures from the environment,
without having to assume independence between exposure events. This paves the way for
more involved modeling efforts such as accounting for healthcare workers and other hospital
surfaces that contain MRSA. Such efforts can be challenging for two reasons: the availability
of high quality data to model behaviors and the computational effort in simulating stochastic
systems. However, they can supplement our understanding of the environment as a source of
MRSA and help devise the most effective control measures in hospitals and the community.
4.4 Methods
4.4.1 Fitting kinetic data
The parameters r1, r2, r3 and imax were identified by minimizing the following objective
function:
∑
c
∑
j
(
log10
(
hc(tj) + ic(tj)
)− log10 (yˆc(tj)))2 (4.10)
Here the subscript c denotes the 3 different initial conditions while tj is the jth observed
time point. yˆ is the measured SA density. Since initially none of the bacteria are adapted
to the environment, i(0) is set to 0. Hence, h(0) is set to the initial inoculating density i.e.,
h(0) = yˆc(0). Using this objective function assumes that both un-adapted and adapted cells
are picked up while taking measurements.
A global optimization algorithm, Differential Evolution Markov Chain (DE-MC, [130]), was
used to minimize the objective function. The algorithm was run for 40000 iterations and 16
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chains were evaluated in parallel. The first half of the solutions were discarded (burn-in). A
MATLAB implementation [25] was used.
4.4.2 Simulating the stochastic model
The adaptive τ leaping algorithm [21] specific to the model was implemented in Python.
Numba was used to speed up the code.
4.4.3 Fitting dose-response data
Running 1000 simulations of the stochastic model is computationally more expensive than
evaluating the deviance for a single value of ithresh with eq. 4.11.
Pres =
no. of sims with (h(t) + i(t))A ≥ ithresh
n
(4.11)
Hence, for a guessed value of b2, simulations were run and the best fitting ithresh was found.
When multiple threshold guesses gave the same lowest deviance, ithresh was set to the mini-
mum of these guesses. The best b2 was found by brute-force search in a hand-tuned interval.
Objective functions were evaluated in parallel using Python’s built-in multiprocessing
module on the High Performance Computing facility at UC Irvine.
4.4.4 Case study
Patients were assumed to occupy the same bed for the duration of 6 days. Exposure to
MRSA was modeled as a Poisson process and assumed to occur at random with a contact
frequency of 0.28 contacts/hour [27]. Hence, the time between two exposure events was
sampled from an exponential distribution with rate parameter = 0.28 contacts/hour.
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Each exposure event resulted in an increase in the number of SA in S1 (unadjusted state).
This inoculation load or increase was computed as the product of 1) MRSA density//cm2
on bed-rails ([78], sampled from a normal distribution with mean = 159.5 CFU/100 cm2,
std. dev. = 396.4 CFU/100 cm2, truncated at (0, 1620)) 2) area of hands ([1], women’s
hand size = 132.42 cm2) 3) transfer efficiency from bedside rails to hands ([2], sampled from
a uniform distribution with bounds [0.22, 0.38]). At each exposure time, the simulation was
halted and the number of SA in S1 was increased by the inoculation load.
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Chapter 5
Discussion
The broad questions I outlined in my dissertation, and the specific questions that I framed
and attempted to answer, concern kinetics of pathogens both outside and within the host. I
have developed mathematical models of these processes and parameterized them with data
from the literature, often relying on a strongly computational approach. I used these models
to make quantitative predictions, generate experimentally verifiable hypotheses, and ask new
questions. The data I used has been around for many years, lending support to the idea
that it is not always necessary to generate new data; sometimes, it suffices to reflect on what
we already know to make progress. Below, I use my work to support my hypothesis - that
mathematical models that account for details and leverage sophisticated techniques open up
new avenues of scientific inquiry and bring existing paradigms into question.
For my first objective (chapter 2), I focused on the safety of using treated wastewater for
agriculture, given that viruses may internalize in the vasculature of the produce. To this
end, I introduced a dynamic model for viral transport from the irrigation water to the final
produce. Specifically, I tracked the biggest cause of gastrointestinal illness in humans - the
human norovirus - in lettuce, which is often eaten uncooked. I modeled lettuce grown in
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soil and hydroponic systems from first principles, accounting for lettuce growth, transport
of virus within lettuce (internalization), natural viral decay, and the attachment of virus
particles to soil particles/walls of hydroponic tanks. I found parameters for the model in
the literature spanning several fields where possible. For the remaining parameters, I used
published data on norovirus internalization [37] to fit the model. In doing the latter, I
greatly benefitted from the computational power of the cluster at UCI, which helped me
simulate the system of ODEs repeatedly to identify good parameter sets. I found that
using treated wastewater (secondary effluent) for irrigating lettuce did not meet the safety
standards of the U.S. EPA nor the WHO. This conclusion was independent of the growth
medium (soil or hydroponics), despite the greater attachment of viruses to the soil. I verified
that the conclusions were robust to several model assumptions by a global sensitivity analysis
– another computationally intensive task. Factors such as the irrigation schedule and time
of harvest were deemed influential by this analysis, highlighting the utility of a dynamic
model. Changing these factors could reduce the risk of virus internalization, a hypothesis
which is experimentally verifiable. The investigation of these interventions would not have
been possible without a detailed model of the processes involved.
For my second objective (chapter 3), I focused on antibiotic-resistant bacteria (ARB), which
have been isolated in several environmental compartments. To meet this need, I modeled
the in-vivo kinetics of bacteria in a host as a simple death process. With this, I was able
to establish a link between the popular exponential and beta-Poisson DRMs and observable
parameters like death rates – in a framework I call the SD (simple death) framework. This
link was analytical for the exponential DRM. I designed an iterative computational procedure
for the beta-Poisson DRM, which is easily parallelized to speed up computation. Further, this
link enabled inquiries into possibilities that were out of reach of the classical framework. For
example, by assuming that ARB act like antibiotic sensitive bacteria (ASB) in the absence
of antibiotics, I was able to predict the probability of the resulting illness responding to
antibiotics. Additionally, I incorporated the effects of antibiotics on dose-response by using
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from in-vitro studies. By parameterizing the model for E. coli and its Gentamicin resistant
variant, I found that a minimal concentration of Gentamicin was sufficient to select for
the Gentamicin resistant strain and result in an illness where Gentamicin would not work.
Moreover, the SD framework can theoretically account for horizontal gene transfer, although
experimental determination of the associated rate constants is a challenge. I also identified
other gaps in data required for an accurate QMRA in the context of the SD framework.
These include the ARB fraction in environmental compartments and the relationship between
antibiotic concentration and death rates for different bacteria.
Towards the third objective (chapter 4), I proposed a two-compartment stochastic model of
bacterial kinetics with cooperativity in action captured by a single parameter. This model
differed from the existing approaches to dose-response modeling, which either adopted in-
dependent action or cooperativity in effect. By developing compiled code that is highly
parallelized and using an optimized tau-leaping simulating algorithm [21], I sped up the sim-
ulation of the stochastic model to fit it to data on S. aureus pathogenesis. Fitting the model
to the data would not have been possible without a cluster, as it was a multi-step proce-
dure involving repeated stochastic simulations of large numbers of species. Nevertheless, this
huge effort paid off when I found that the hypothesis of cooperativity in action cannot be
rejected. I was able to show, for the first time, that synergistic interaction between bacteria
(or quorum sensing) can account for their ability to initiate disease symptoms. This differs
from the traditional assumption of independent action in dose-response modeling, wherein
each bacterium is assumed to act independently.
I believe that the arguments presented above stand in support of my hypothesis.
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Appendix A
A transport model for quantifying
norovirus internalization in lettuce
A.1 Hydroponic growth medium
A.1.1 Justifying the setting of rate of volume reduction to rate of
transpiration
Hydroponic tanks face water loss by two processes, evaporation and transpiration. [28] used
generalized linear models to fit the rate of evapotranspiration (ET) in hydroponically grown
lettuce. They found that the air temperature and vapor pressure deficit had the lowest
significance among the covariates considered. Taken together with the marked increase in
water usage as the lettuce grows, the evaporation component in ET is thought to be less
important in the hydroponic system. Hence, I made a simplifying assumption that the rate
of ET, rather than the rate of transpiration, drives viral transport. I equated the flow rate
to the rate of ET for these reasons.
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A.1.2 Volume of shoot
The growth model for the lettuce shoot dry weight (given below) was obtained from [28],
which was first introduced in [17]. I converted the dry weight to fresh weight using the
dry:fresh weight ratio dshoot,h=0.045 [16] and shoot density ρshoot=0.35 g/cm3 [72].
M ′shoot(t) = exp(s1 + s2t+ s3t2)
M ′shoot(t) is the rate of accumulation of dry mass (g dry wt/ mL). s1, s2 and s3 are as defined
in Table 2.2. Volumetric growth rate is given by eq. (2.8), Table 2.1.
A.1.3 Volume of roots
I obtained the growth model for the lettuce root dry weight from [16]. I converted this to
fresh weight using the dry:fresh weight ratio (droot,h=0.057) estimated from [152] white LED
with no supplemental light). I assumed a density ρshoot=0.2 g/cm3.
M ′root(t) = exp(r1 + r2t+ r3t2)
M ′root(t) is rate of accumulation of dry mass (g dry wt/ mL). r1, r2 and r3 are as defined in
Table 2.2. Volumetric growth rate is given by eq. (2.7), Table 2.1.
A.1.4 Water volume fitting considerations
While [28] found that the rate of dry mass accumulation had the highest significance, I could
not use the coefficients (at, bt) they provided. This is because the cumulative water usage
predicted by those coefficients in the monitored period is higher than the tank volume of
800 mL specified by [37]. To account for the lower water usage, I fitted the coefficients while
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maintaining the conclusion of the experiment that the rate of ET is a linear function of the
dry mass accumulation rate.
A.2 Soil growth medium
A.2.1 Volume of envelope
The reported soil envelope volume (Ve) in the lettuce Rainha De Maio in [106] for different
soil types varied from 3332 – 8568 cm3 although the growth stage is not reported. [140] used
a different cultivar (Early Prize Head) and very different estimates were obtained, especially
for the later stages of growth. Fitting a cone of radius 3.46 inches and height 6 inches in the
early stage gives a volume of 3706 cm3. Fitting a cone of radius 1.5 feet and height 5 feet
gives a volume of 3.336×105 cm3 for the mature stage. Using these numbers as guidelines, I
fixed the soil envelope volume (Ve) to 80000 cm3 and verified the low sensitivity of the risk
estimates to large variations in this parameter (Fig. 2.5).
A.2.2 Volume of shoot
[128] compared 3 lettuce growth models – the logistic, Gompertz [51] and the expolinear
[52] model. I chose the logistic model (eq. (2.8), Table 2.1), despite its higher root mean
squared error, because there are insufficient data to simulate the expolinear and Gompertz
models. This model predicts dry weight/area, and I extended it to fresh volume per unit
plant because: 1) The number of plants per unit area (np=17.6 plants/m2) remains constant
over the course of that experiment [129]; 2) The ratio of dry weight: fresh weight (dshoot,s)
remains constant over the lettuce growth phase [16] ; 3) The density of the shoot (ρshoot)
remains constant over the growth phase. The growth equation in dry weight/area (W (t))
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over time is given by:
dW (t)
dt
= rgW (t)
(
1− W (t)
Wf
)
where wf is the final dry weight per unit area. Substituting W (t) = Vsh(t)npdshoot,hρshoot
and Wf = wfnpdshoot,h (where wf is the final fresh weight per plant), eq. (2.8), Table 2.1 is
obtained. Hence the same growth rate constant r is applicable for the fresh volume model.
I took the final fresh weight (wf ) and density (ρshoot) from [72] for the Ithaca variety.
A.2.3 Flow rate
[45] used a model to predict the transpiration rate (in mm day−1) of lettuce over its growth
phase in soil. To get the volumetric flow rate, I multiplied by an arbitrary area and divided
by the number of plants in that area:
F (mL plant−1day−1) = ROT (mm day−1)× area
no. plants in that area
where F is the flow rate and ROT is the rate of transpiration. Since lettuce was reportedly to
occupy three fourths of the total area at harvest time (the rest occupied by soil), I computed
the per plant transpiration rate by considering an area of 1m2 using:
F (mL plant−1day−1) =
ROT (cm day−1)
10
× 1m
2
0.75m2 ÷ area of fully grown lettuce
I obtained the ROT from figure 3 in [45] using WebPlotDigitizer [115] and converted it to
flow rate using the method described above.
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A.2.4 Model fitting and diagnostics
I fitted log10 of the viral concentration because viral concentrations at different time points
differed by orders of magnitude. Fitting concentrations resulted in a good fit for early time
points but inaccurate estimates for later timepoints used in estimating the risk. While max-
imizing the likelihood of the log10 concentration, I did not weight by the standard deviations
as these estimates were from small sample numbers [97]. I did not pursue multiobjective
approaches to simultaneously maximize the individual likelihoods of water, root, and shoot
concentrations due to the similar orders of magnitude of the likelihoods. For the same reason,
I did not weight likelihoods differently.
I also investigated convergence diagnostics. I discarded the first half of the 20000 iterations
of DE-MC (burn-in). I identified outlier chains by their characteristic higher mean objective
function value compared to other chains and discarded them. The Rˆ values [48] of the
remaining chains were close to 1 (data not shown). I randomly subsampled the samples
from these chains (after burn-in and outlier removal) and used them for further analysis.
A.2.5 Sensitivity analysis
Parameter Fixedvalue
Lower
bound
Upper
bound Source
ρshoot 0.35 0.27 0.35 Other lettuce densities in
droot,h(t) 0.057 0.0444 0.071
95% quantile by assuming normal
distributed root weights [152]
dshoot,h 0.045 0.04 0.05 From [16]
ρroot,h 0.2 0.1 1
Assumed to span one order of
magnitude.
tht,h 14 12 16 Assumed two-day difference
tg,h (0) 800 600 6000
Assumed from experiment, span
one order of magnitude
tli,h 21 19 23 Assumed two-day difference
Ve 80000 8000 80000
Assumed to span one order of
magnitude
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θ 0.435 0.435 0.476
Ranging from sandy loam to clay
loam (no loamy sand or sand)
from [29]
kdec,s 0.15 0.15 0.199
Surface applied, PBS, 2 soil types
from Roberts.et al 2016
Vroot,s(t) 100 30 300
Assumed to span one order of
magnitude
rg 0.2056 0.203 0.2082 From standard error in [128]
wf 550 335 550 From [72]
katt,s 4.1, 0.8 0.8 4.1 From [121]
kdet,s
0.00087,
0.003 0.00087 0.003
tht,s(t) 14 12 16 Assumed two-day difference
Table A.1: Sensitivity analysis parameters
A.3 Figures
Figure A.1: Comparison of risks by increasing holding time of lettuce after harvesting from
soil (A) or increasing tank volume of hydroponic grown lettuce (B). Both strategies failed to
reduce risk below the acceptable limits.
93
Figure A.2: Illustration of the difference in response to delay input for a time invariant vs.
a time variant system. An input pulse at t = 0 produces the response in the top right panel
for time invariant and time variant systems. Shifting the input pulse to t = 10 produces
a shifted (but same shape of blue lines) response in the time invariant case but a different
characteristic response (different shape of orange lines) in the time variant case. Time to
reach a response of 0.4 remains in the same relative position (tinvar) for the time invariant
system whereas it shifts (tvar to tvar,2) for the time variant system, showing non-unique times
for reaching the same response.
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Figure A.3: Comparison of the viral concentration in the growth medium (water) and lettuce
shoot using models with and without incorporation of AD of viruses to hydroponic tank walls.
In this simulation, a lower katt,s value (one tenth of the best fit parameter from the) was
used. The model without AD underestimates the viral load in the lettuce.
Figure A.4: Illustration of median(log10(risk)) as a function of AD kinetic parameters for
soil grown lettuce, β Poisson risk model. Simply replacing katt,s and kdet,s with the medians
of katt,h and kdet,h in the soil model drastically reduces the median(log10(risk)). Comparing
numerical values of median(log10(risk)) listed above (see Table 2.3) with Fig. 2.4 (top panel,
median of β Poisson boxes) shows that a change in AD kinetic parameters exerts a major
influence in determining the magnitude of risk.
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Figure A.5: Histograms of the pairwise distances of annual risk estimates (Sc1), Pill,ann for
the different dose-response models. Pairwise distance is a measure of variability with lower
distances indicative of less variability. The within dose-response model variability (solid
lines) are lesser than between dose-response model variability (dashed lines).
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Appendix B
Quantifying the infection risk of
antibiotic-resistant bacteria
B.1 Datasets used
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ID [Ref] Dose nill ntot tfs(days)
DS1 [127]
1.00e+04 0 5
1
1.00e+04 0 5
1.00e+06 0 5
1.00e+06 1 9
1.00e+08 5 8
1.00e+08 3 5
DS2 [127]
1.00e+06 0 4
2.625
1.00e+06 1 5
1.00e+08 1 5
5.00e+08 3 5
2.50e+09 6 6
1.00e+10 9 10
1.00e+10 9 14
1.00e+10 3 5
1.00e+10 5 5
2.00e+10 2 2
2.30e+10 14 19
Table B.1: Datasets used in chapter 3.
B.2 Parameter ranges for sensitivity analysis
Parameter Units Lower bound Upper bound
C mg L−1 0.00 0.05
fr - 0.00 0.10
log10(d) - 1.00 4.00
Emax* day−1 612.00 1836.00
EC50* mg L−1 4.96 14.89
r* CFU−1 5.33×10−9 1.59×10−8
tfs days 1.50 2.50
Table B.2: Parameter ranges for exponential model. Parameters with * are increased and
decreased by 50% of the values used in Fig. 3.2.
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Parameter Units Lower bound Upper bound
C mg L−1 0.00 0.05
fr - 0.00 0.10
log10(d) - 1.00 4.00
Emax* day−1 612.00 1836.00
EC50* mg L−1 4.96 14.89
α* - 0.08 0.24
β* - 7.07×106 2.12×107
tfs days 2 3
Table B.3: Parameter ranges for beta-Poisson model. Parameters with * are increased and
decreased by 50% of the values used in Fig. 3.2.
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B.3 beta-Poisson procedure verification
Figure B.1: Verify conversion procedure for beta-Poisson model. (A) Plot of µ at various
concentration. (B) Comparison of empirical CDF of the sampled r values and the CDF from
the fitted Beta distributions. The analytical CDF at 0% MIC is also shown for comparison.
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B.4 Methods
B.4.1 Using the Simple Death DRM
Suppose one is interested in calculating the response for a pathogen. It is present in an
exposure case with d = 1000, with 20% of the pathogen being resistant to an antibiotic, and
the concentration of antibiotic is C = 0.025×MIC (2µg mL−1) = 0.05µg mL−1.
• Identify dose-response data for the pathogen. This can be like DS1 or DS2 listed in
Table B.1.
• Identify tfs. This is the latest time at which some subject shows the first symptom.
Suppose tfs = 1 day
• Identify Emax and EC50 for the antibiotic-pathogen combination of interest. Suppose
Emax = = 1224 day−1and EC50 = 9.93 mg L−1= 9.93 µg mL−1.
• Fit both exponential and beta-Poisson models to this dataset and identify the best
fitting model, using methods outlined in [57].
• If best fitting model is exponential, go to section B.4.2. If best fitting model is
beta-Poisson, go to section B.4.3.
The sensitivity analyses indicate that getting approximate values for tfs is sufficient to predict
response. However, it’s value is critical to accurately estimate death rate (µ) if using the
exponential DRM.
B.4.2 Using exponential DRM
The exponential model is given by:
P (d) = 1− exp (−rd)
101
Suppose the best fit for r is given by rˆ = 1.07× 10−8.
• Compute µ by solving
(1− exp(−µtfs)) = exp(−rˆ)
to get
µ = − log(1− exp(−rˆ))/tfs = 7.97 day−1
• Compute µs,AB(C) using
µs,AB(C) = µ+
EmaxC
EC50 + C
= 7.97day−1 +
1224 day−1 × 0.05µg mL−1
(9.93 + 0.05)µg mL−1
= 14.10 day−1
• Set µr,AB = µ = 7.97 day−1
• Compute extinction probabilities for the susceptible and resistant subpopulations using
Pext,s(d|fr, C) = (1− exp(−µs,AB(C)tfs))d×(1−fr) ≈ 0.999400822
and
Pext,r(d|fr, C) = (1− exp(−µr,ABtfs))d×fr ≈ 0.933317727
• Compute total response probability with
P (d|fr, C) = 1− Pext,s(d|fr, C)Pext,r(d|fr, C) ≈ 0.067241497
• If (1−Pext,s(d, t|fr, C))Pext,r(d, t|fr, C) > (1−Pext,r(d, t|fr, C)), illness is AB treatable.
If not, illness is not AB treatable. In this case, this condition evaluates to False and
hence the illness is likely not AB treatable.
B.4.3 Using beta-Poisson DRM
The beta-Poisson DRM is given by
P (d) = 1−
(
1 +
(d
β
))−α
Suppose the best fit parameters are αˆ ≈ 0.1615058 and βˆ = 1414958. Computing response
probabilities is more involved and requires access to a function that can fit a beta distribution,
such as the fitdistrplus package in R [36].
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• From the values of αˆ, βˆ, Emax, EC50 and C, compute αs and βs for the susceptible
subpopulation. For this, use the algorithm outlined in the Methods section. We get
αs = 0.1613020 and βs = 1.295420× 1013.
• Set αr = αˆ and βr = βˆ for the resistant subpopulation.
• Compute extinction probabilities for the susceptible and resistant subpopulations using
Pext,s(d|fr, C) =
(
1 +
(d× (1− fr)
βs
))−αs
= 1
and
Pext,r(d|fr, C) =
(
1 +
(d× fr
βr
))−αr
≈ 0.999977202
• Compute total response probability with
P (d|fr, C) = 1− Pext,s(d|fr, C)Pext,r(d|fr, C) ≈ 2.28× 10−5
• If (1−Pext,s(d, t|fr, C))Pext,r(d, t|fr, C) > (1−Pext,r(d, t|fr, C)), illness is AB treatable.
If not, illness is not AB treatable. In this case, this condition evaluates to False and
hence the illness is likely AB untreatble.
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Appendix C
Role of quorum sensing in microbial
pathogensis
C.1 Fitted parameter values
r1 r2 r3 imax b2 ithresh Fgr Fdr
(/day) (/day) (cm2/ (CFU day)) (CFU/cm2) (/day) (1/(CFU day))
1.94 1.47e-02 2.71e-07 1.18e+07 1.70 7.34e+06 0.57 8.67
1.90 1.55e-02 3.56e-07 8.93e+06 2.00 4.81e+06 0.60 8.01
2.10 2.68e-02 2.92e-07 1.05e+07 0.70 2.04e+07 0.61 7.46
2.19 1.95e-02 3.53e-07 9.09e+06 1.80 6.88e+06 0.64 6.83
1.69 1.02e-02 3.91e-07 8.70e+06 1.70 7.97e+06 0.68 6.34
Table C.1: Rank 1 solutions in increasing order of Fgr, the growth-objective (eq. 4.10). Fdr
is the dose-response objective (eq. 4.5). Remaining parameters are defined in chapter 4.
C.2 Comparing MRSA and MSSA growth
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Study MSSA strain MRSA strain ρ
[79] 1999 494 0.8505
[9] O9 P22 0.9461
[39]* 1492 211 0.9843
[76]* 29213 43300 0.9995
Table C.2: Pearson correlation coefficients (represented by ρ) for growth curves of vari-
ous strains of MSSA and MRSA. * represents median of the several correlation coefficients
computed
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